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DiGeorge syndrome, characterized by congenital heart disease, craniofacial and 
immune system abnormalities, is the most common microdeletion syndrome with an 
incidence of 1 in 4000 live births. Congenital cardiac defects including conotruncal and 
ventricular septal defects are the leading cause of mortality. Experiments in mouse have 
identified Tbx1 as the gene responsible for DiGeorge syndrome, and these findings were 
subsequently corroborated in human patients. However, the underlying pathways of Tbx1 
regulating heart, craniofacial and thymus development remain to be fully characterized. 
My dissertation focuses on using the zebrafish tbx1
-/-
 mutant with craniofacial and 
immune defects similar to DiGeorge syndrome patients, to study the role and pathways of 
tbx1 regulating heart and cartilage development.  
I found that tbx1
-/-
 mutants have defects in heart morphology, looping, function 
and differentiation. I showed that tbx1 likely affects heart looping and differentiation by 
regulating cardiomyocyte proliferation and shape. I further demonstrated that tbx1 
regulates heart looping and differentiation via wnt11r and its downstream gene alcama.  
In addition to heart defects alcama morphants present cartilage abnormalities similar to 
those obtained by knockdown of edn1, a gene previously identified to act downstream of 
tbx1 in cartilage development. Further investigation revealed that alcama functions 
downstream of Edn1 signaling in regulating neural crest differentiation and cartilage 
formation. In addition, I showed that Alcama on endoderm interacts with Nadl1.1 on 
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neural crest to mediate Edn1 signaling and regulate cartilage morphogenesis. Hence, I 
have demonstrated that Tbx1 regulates Alcama via Wnt11r in the heart and via Edn1 in 
























For My Parents 
  
 





1.   INTRODUCTION ........................................................................................ 1 
 
1.1   TBX1 is responsible for DGS ................................................................. 2 
1.2   TBX1 functions in a dose-dependent manner........................................... 3 
1.3   Tbx1 expression ...................................................................................... 4 
1.4   Zebrafish as a model to study DGS......................................................... 5 
1.5   Heart development.................................................................................. 6 
1.6   Cartilage development ............................................................................ 11 
1.7   References .............................................................................................. 20 
 
2.   DIGEORGE SYNDROME GENE TBX1 FUNCTIONS THROUGH  
WNT11R TO REGULATE HEART MORPHOLOGY AND FUNCTION .......... 26 
 
2.1   Abstract .................................................................................................. 27 
2.2   Keywords ............................................................................................... 27 
2.3   Introduction ............................................................................................ 28 
2.4   Materials and methods ............................................................................ 31 
2.5   Results.................................................................................................... 35 
2.6   Discussion .............................................................................................. 45 
2.7   Conclusion.............................................................................................. 49 
2.8   Acknowledgments .................................................................................. 50 
2.9   References .............................................................................................. 71 
 
3.   ALCAMA REGULATION OF CARTILAGE MORPHOGENESIS............. 75 
 
3.1   Abstract .................................................................................................. 76 
3.2   Introduction ............................................................................................ 76 
3.3   Materials and methods............................................................................ 77 
3.4   Results.................................................................................................... 78 
3.5   Discussion .............................................................................................. 83 
3.6   Conclusion ............................................................................................. 86 
vii
3.7   Acknowledgement.................................................................................. 86 
3.8   References.............................................................................................. 86 
 
   4.   CONCLUSIONS .......................................................................................... 87 
4.1   Tbx1 regulates heart morphology and differentiation .............................. 87 
4.2   tbx1 regulates heart morphogenesis via wnt11r ....................................... 89 
4.3   Alcama is required for proper cartilage morphogenesis........................... 91 
4.4   Alcama functions downstream of Edn1 signaling.................................... 92 
4.5   Alcama interacts with Nadl1.1 on NC to mediate Edn1 signaling............ 94 










I would like to express special gratitude to my advisor, Nikolaus Trede, for his 
guidance and support during my graduate career. His energy, enthusiasm and love for 
science have given me motivation and courage especially during hard times. He has been 
very patient and encouraging, helping me to become a better scientist by encouraging me 
to think on my own. I also thank the rest of my committee: Dean Li, Joseph Yost, Tatjana 
Piotrowski and Jody Rosenblatt for their guidance, critical insights and helpful 
suggestions.  
My sincere thanks to the members of the Trede lab, who have helped and 
encouraged me during my development as a scientist. They have helped me tremendously 
by showing me how to do experiments, give talks and write scientific documents in 
addition to providing friendship and support. Particularly noteworthy are Sarah 
Hutchinson, Deepa Joshi and Diana Bradley. Thank you to people in the CZAR for 
taking care of my fish and the microscopy and other core facilities for helping me obtain 
and analyze my results. Thank you to the people who have shared their plasmids and 
antibodies, particularly Shiela Samson and Josh Wythe. Thank you to the people from the 
Molecular Biology Program, Department of Oncological Sciences and Zebrafish Interest 
Group who have lent me technical support, and have provided a friendly and supportive 
environment for research. Thank you to Barbara Saffel, Tami Brunson, Dee DalPonte, 
 ix
Jessica Hampton, and the International Center staff for making sure I stay in good 
academic and visa status. 
Most importantly, I want to thank my parents for encouraging and supporting me 
during hard times. I have felt your love across the distance and will be forever grateful 
for your understanding. My brother has been my best friend and biggest supporter. To my 
friends here in Salt Lake City, you have helped me make a home away from home and 













DiGeorge syndrome (DGS), characterized by cardiac abnormalities, craniofacial 
defects and thymus hypoplasia, is the most common microdeletion syndrome occurring in 
1/4000 live births (Oskarsdottir et al., 2004). The clinical characteristics and severity of 
DGS are highly variable. The disease is predominantly sporadic and approximately 6-
10% of cases are familial; sometimes one of the parents is identified only after a more 
severely affected child is diagnosed. Approximately 75-80% of patients have congenital 
heart disease with conotruncal defects (tetralogy of Fallot, aortic arch defects, and truncus 
arteriosus) and ventricular septal defects. Aortic arch defects include double aortic arch, 
right-sided aortic arch, cervical aortic arch and aberrant origin of subclavian arteries. 80% 
of patients have thymic hypoplasia resulting in decreased T cell numbers, but most are 
not clinically immunodeficient. IgA deficiency has also been identified. About 0.5% of 
cases have complete absence of T cells. This form is called Complete DGS and these 
patients require thymic transplantion as early as possible. Other features include 
hypocalcemia (resulting from parathyroid gland hypoplasia), palate anomalies, 
craniofacial abnormalities (auricular anomalies, small mouth, micrognathia, a short 
forehead, and some midfacial flattening), renal anomalies (urinary tract or renal agenesis 
or multidysplastic kidneys) neurological defects, speech disabilities, and feeding 
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disorders (Goldmuntz, 2005). Most of these affected structures are derived from the 
pharyngeal apparatus of the developing embryo, suggesting that DGS is a developmental 
defect arising during embryogenesis. I will now focus on the genetic basis of DGS.  
 
1.1 TBX1 is responsible for DGS 
Most DGS patients have a 3Mb or a nested 1.5 Mb deletion of chromosome 
22q11, implicating haploinsufficiency of a gene in the 1.5 Mb region (Morrow et al., 
1995). To identify the gene responsible for the DGS phenotype among the 25 genes that 
map to the critical interval, various mice with deletions in the homologous region on 
chromosome 16 were generated (Fig. 1.1). Df1/+ mice carrying a 1.2 Mb deletion had 
outflow tract defects, suggesting that the critical gene was located in this region (Lindsay 
et al., 1999). A 550 Kb deletion of the proximal half of this region generated mice with 
no conotruncal abnormalities eliminating 13 genes (Puech et al., 2000). Mice with a large 
deletion spanning 1.5Mb (Lgdel/+) containing 24 genes exhibited parathyroid gland 
aplasia and perinatal lethality in addition to conotruncal anomalies (Merscher et al., 
2001). These defects were rescued by complementation with BAC 316, thus narrowing 
the candidate genes to four: Pnutl, Gp1b?, Tbx1 and Wdvcf.  
Only Tbx1 is expressed in the pharyngeal apparatus, from which the craniofacial 
skeleton, thyroid, parathyroid and thymus are derived. Tbx1
+/-
 mice have mild 
cardiovascular defects and ectopic parathyroid glands and are viable (Lindsay et al., 
2001).  Tbx1
-/-
 mice have a severe phenotype with single cardiac outflow tract, aortic arch 
defects, thymus and parathyroid gland aplasia, absent outer and inner ear, cleft palate and 
neonatal lethality (Jerome and Papaioannou, 2001). Several frame-shift and missense 
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mutations in TBX1 have been found in patients with a 22q11.2-like phenotype but 
without the chromosomal deletion, strongly suggesting that DGS is caused by 
haploinsufficiency of TBX1 (Gong et al., 2001; Yagi et al., 2003). We will now examine 
TBX1 function in more detail.  
 
1.2   TBX1 functions in a dose-dependent manner 
 
Tbx1 is a member of the T-box gene family, a family of transcription factors that 
are characterized by a highly conserved DNA-binding region, the T box. The T-box also 
serves as an interaction domain for other transcription factors, and chromatin and histone 
modifying enzymes (Ryan and Chin, 2003; Smith, 1999). T-box proteins often function 
in combination with other transcription regulators or in a hierarchy, and are dose-
dependent in their action. The dose-dependency of Tbx1 was confirmed by generating 
mouse transgenics. Mice carrying a duplication of the syntenic 22q11.2 region that is 
deleted in DGS and mice containing 8-10 copies of human TBX1 exhibit some similarity 
to DGS patients (Ensenauer et al., 2003; Merscher et al., 2001). Normalization of TBX1 
expression by a gain of 8-10 copies of human TBX1, on a Tbx1-/- background rescues the 
DGS malformations (Liao et al., 2004). Additionally, 2 missense mutations, F148Y & 
H194Q found to cause DGS may function by increasing dimer stability and/or DNA 
affinity (Zweier et al., 2007). These findings indicate that TBX1 operates in a dose-
dependent manner, thus explaining why TBX1 haploinsufficiency causes DGS in humans. 
This leads me to study the expression and role of Tbx1.  
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1.3   Tbx1 expression 
 
Most of the tissues and organs affected in DGS are derived from the pharyngeal 
apparatus, a vertebrate-specific, transient embryonic structure that gives rise to feeding 
and respiratory structures as well as the thyroid, parathyroid and thymus. The pharyngeal 
apparatus consists of five pharyngeal arches arising as a series of bulges on the lateral 
surface of the embryo. Cranial neural crest cells migrate from the rhombomeres to 
surround the core mesoderm of the pharyngeal arches. Each pharyngeal arch is composed 
of a cylinder of neural crest cells surrounding a core of mesodermal cells. The arches are 
separated from each other by ectoderm-lined pharyngeal clefts and endoderm-lined 
pharyngeal pouches.  
Tbx1 is expressed in surface ectoderm, pharyngeal endoderm and core mesoderm 
but not neural crest (Fig. 1.2)(Vitelli et al., 2002). However, Tbx1 mutation disrupts the 
migration of neural crest cells into the arches (Vitelli et al., 2002). Both conditional 
pharyngeal endoderm-specific and mesoderm-specific Tbx1 null mice have 
malformations similar to those in Tbx1 homozygous null mutants including thymus 
hypoplasia and cardiovascular defects (Arnold et al., 2006; Zhang et al., 2006). These 
data indicate that Tbx1 expression in pharyngeal endoderm and mesoderm is necessary 
for proper patterning of the pharyngeal apparatus and proper formation of thymus and 
cardiac system.  
Zebrafish tbx1 is highly similar to mouse Tbx1 in sequence and exon-intron 
structure. tbx1 is first detected by in situ hybridization (ISH) at 6hpf during gastrulation 
in the involuting hypoblast cells and by 6-10 somites it is expressed in the paraxial 
mesoderm (Fig. 1.2) (Piotrowski et al., 2003). By 27 somites it is restricted to the 
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mesodermal core and epithelia of arches and the linear heart tube. From 48hpf tbx1 
expression is seen in individual arch muscles, pharyngeal endoderm, ear and heart. Thus, 
the expression of tbx1 is conserved between mice and zebrafish. I have used zebrafish as 
a model system to study DGS.  
 
1.4   Zebrafish as a model to study DGS 
 
Though Tbx1 is an important developmental gene, and several mouse mutants 
have been generated, little is known about its downstream targets and pathways.  New 
animal models that have a simpler developmental program and are easy to manipulate 
and examine are needed. Both heart and cartilage development is well described in 
zebrafish embryos and a plethora of developmental and structural markers is available. 
Transparency of the embryos allows live assessment of cardiac function, cellular 
morphology and cartilage/jaw structure.  




 has a premature stop codon in the T-box 
domain of tbx1 (Piotrowski et al., 2003). The phenotypic similarities to DGS are striking 
with the exception that unlike mice and humans, the mutation is recessive in zebrafish. 
Homozygous mutants lack a thymus and pharyngeal pouches 2-6, resulting in fusion and 
loss of posterior pharyngeal arch-derived cartilage. In addition mutant embryos have 
reduced aortic arches, small otic vesicles and pericardiac edema. This dissertation will 
focus on identifying new targets of tbx1 by studying heart and cartilage development in 
the zebrafish tbx1
-/-
 mutant. This will, I hope, promote a deeper understanding of the 
molecular players involved and lead to better therapies. Before characterization of heart 
defects in tbx1
-/-
 mutants, I will give an overview of heart development.  
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1.5   Heart development 
Myocardial progenitors of the primary heart field (PHF) arise bilaterally, within 
the anterior portions of the lateral plate mesoderm as early as 10 somites (Brand, 2003; 
Yelon, 2001). The cardiomyocytes move toward the midline and begin cardiac fusion 
ending with a shallow cone with a central lumen (Fig. 1.3). The cone tilts and extends, 
forming the linear heart tube (LHT) by 24 hpf. Circulation begins at this stage and the 
heart tube extends from the midline to under the left eye. The ventricle jogs towards the 
midline by 33 hpf, curving the tube. The tube continues to bend and twist forming the 
completely looped heart by 48 hpf (Fig. 1.3).  
At this stage, the heart is regionally specified to form the inflow tract (IFT), 
atrium, atrioventricular canal (AVC), ventricle and outflow tract (OFT). The ventricle is 
to the right of the atrium and the chambers look like inflated balloons with constrictions 
at both of their ends and the heart is fully functional. The early stages in the process of 
heart development are conserved among various organisms. Similar to zebrafish, the PHF 
arises as bilateral fields but their migration forms a cardiac crescent in mice, rather than a 
cardiac cone (Brand, 2003). In addition, the looping process continues on further to yield 
a four-chambered heart as compared to a two-chambered heart in zebrafish.  
The secondary heart field (SHF) originates from the splanchnic mesoderm, medial 
to the PHF (Waldo et al., 2001). Cells from the SHF migrate towards the midline 
similar to the cells of PHF, but position themselves at the arterial pole of the heart tube. 
As the heart loops, these cells are added to the OFT and ventricle (Kelly and 
Buckingham, 2002). The SHF has been recently discovered in zebrafish. Similar to chick 
and mouse, the SHF cells are found in the most medial portion of the mesodermal heart 
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fields, migrate to the arterial pole after heart tube formation and later contribute to the 
bulbous arteriosus (BA) and ventricle (Hami et al., 2011). 
 
1.5.1   Signaling pathways involved in heart development 
Heart development is a complex process involving several pathways in a 
spatiotemporally regulated pattern. Study of signaling pathways during heart 
development has relied mainly on gene expression analysis and various mutants in 
Drosophila, zebrafish and mice. Gene expression analysis reveals that the PHF is already 
specified and patterned by the onset of somitogenesis (Yelon, 2001). Specified 
cardiomyocytes are marked by the expression of transcription factors gata4, hand2 and 
nkx2.5. Mutants for the genes, gata5, fgf8, bmp2b, and one-eyed pinhead (oep) have 
reduced expression of nkx2.5, showing that these genes play a role in myocardial 
specification.  
A different set of genes, including several T-box transcription factors, has been 
implicated in directing cardiac looping. The heart fails to loop in the zebrafish tbx5-/- 
mutant and tbx20 has been shown to affect heart looping by negatively regulating tbx5 
expression (Brown et al., 2005; Garrity et al., 2002). Additionally, morpholino 
knockdown of tbx2a and tbx3b in zebrafish results in lack of heart looping and AVC 
formation (Ribeiro et al., 2007). Loss of noncanonical wnt11r signaling has also been 
shown to affect cardiac looping in Xenopus (Gessert et al., 2008). The relationship 
between these genes with respect to regulation of cardiac looping has not been 
determined so far.  
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The process and mechanism of cardiac looping is poorly understood. The signals 
directing migration and the signals creating competence to respond to migration signals 
are not known. It has been hypothesized that cardiac looping is driven by changes in cell 
shape (Auman et al., 2007) and cell proliferation (Qu et al., 2008; Ribeiro et al., 2007).  
Concomitant with looping, expression of several genes such as notch1b becomes 
restricted to specific regions of the heart. However, lack of looping in zebrafish 
morphants is often accompanied by defective expression of these region-specific genes. 
For example, notch1b expression is expanded into the ventricular endocardium of tbx3b 
and tbx2a morphant embryos (Ribeiro et al., 2007). Whether this region-specific 
expression induces abnormal looping directly, or is a secondary defect thereof, has not 
been determined.  
In summary, these pathways cooperate or antagonize each other to 
promote cardiac morphogenesis. The hierarchy, epistasis and relationship between these 
signaling pathways with respect to heart morphogenesis remains to be elucidated. In this 
thesis I have examined if any of these pathways and mechanisms are mis-regulated in the 
hearts of the tbx1
-/-
 mutant. My results suggest that tbx1 regulates heart looping and 
subspecification via wnt11r  and alcama. I will now summarize the literature regarding 
wnt11r and heart morphogenesis.  
 
1.5.2   Wnt11r 
Several publications indicate that Wnt11 signaling plays an important role during 
cardiac development. In Xenopus, maternal Wnt11 protein is enriched in the presumptive 
dorsal mesoderm and as zygotic transcription commences it becomes localized to the 
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dorsal marginal zone (Brade et al., 2006; Eisenberg and Eisenberg, 2006). Wnt11 
expression shows a conserved expression in precardiac mesoderm in quail, chick, mouse 
and Xenopus (Brade et al., 2006). Blocking Wnt11 signaling inhibits cardiac specification 
while ectopic expression of Wnt11 induces cardiac gene expression (Eisenberg and 
Eisenberg, 1999; Pandur et al., 2002; Schneider and Mercola, 2001). Furthermore Wnt11 
can induce expression of cardiac genes in Xenopus explants and noncardiac cells from 
humans and mouse (Belema Bedada et al., 2005; Eisenberg and Eisenberg, 1999; 
Flaherty et al., 2008; Garriock et al., 2005; Pandur et al., 2002; Schneider and Mercola, 
2001; Ueno et al., 2007).  
Garriock et. al. characterized wnt11r, a second wnt11 gene in Xenopus and 
zebrafish that is an ortholog of chick and mammalian Wnt11 (Garriock et al., 2005). 
Unlike wnt11, wnt11r is not required for cardiac specification and does not form 
secondary axes when mis-expressed in Xenopus embryos. wnt11r  expression begins in 
primary cardiac fields at the onset of differentiation, just prior to fusion of the heart tube 
and persists as the heart develops. Consistent with its expression pattern, knockdown of 
wnt11r leads to defects in heart morphogenesis and cardia bifida in some cases (Garriock 
et al., 2005). Furthermore, mutations in mouse Wnt11 cause cardiac OFT defects such as 
truncus arteriosus, similar to those observed in Tbx1-/- mutants (Zhou et al., 2007). While 
both Tbx1 and Wnt11 signaling have been shown to be important in heart morphogenesis, 
my results provide the first link between them.  
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1.5.3   Alcama 
 Activated Leukocyte Cell Adhesion Molecule (ALCAM or Alcama in zebrafish), 
also known as CD166/neurolin/BEN/DM-GRASP/SC1/HCA, is a cell surface 
immunologlobulin superfamily member. Human ALCAM is a transmembrane 
glycoprotein having five immunoglobulin domains, a transmembrane domain and a short 
cytoplasmic tail. While it was initially identified in chicken for its role in neurite 
extension (Burns et al., 1991), ALCAM has now been shown to be involved in axonal 
pathfinding and axonal fasciculation (Diekmann and Stuermer, 2009; Weiner et al., 
2004). In zebrafish, Alcama has been studied primarily for its role in neurogenesis 
(Diekmann and Stuermer, 2009; Fashena and Westerfield, 1999), although it is active in 
several other processes. Notably, ALCAM is expressed on dendritic and endothelial cells 
and can activate T-cells by binding to the CD6 receptor (Bowen et al., 2000; Fashena and 
Westerfield, 1999; Ofori-Acquah and King, 2008; Zimmerman et al., 2006). Furthermore, 
ALCAM has been shown to play a role in metastasis (Degen et al., 1998; Ofori-Acquah 
and King, 2008) and cell migration (Heffron and Golden, 2000).  
ALCAM has a characteristic VVCCC immunoglobulin motif that is capable of 
interacting with itself or with other immunoglobulin motifs. It mediates cell-cell 
clustering through homophilic (ALCAM-ALCAM) as well as heterophilic (ALCAM-
NgCAM and ALCAM-CD6) interactions (Bowen et al., 2000; DeBernardo and Chang, 
1996; Degen et al., 1998). While Alcama is commonly used as a marker for pharyngeal 
endoderm and myocardium in zebrafish (Beis et al., 2005; Crump et al., 2004; Piotrowski 
and Nusslein-Volhard, 2000), its role in these tissues has not been elucidated thus far. 
However, alcama has been implicated to work downstream of wnt11r in regulating heart 
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morphogenesis in Xenopus (Gessert et al., 2008). In this thesis I have established that 
tbx1, wnt11r and alcama function in a linear pathway regulating heart morphogenesis in 
zebrafish. Furthermore, I have shown that alcama functions downstream of tbx1 in 
cartilage morphogenesis. Before I do so, let me review cartilage development.  
 
1.6   Cartilage development 
Cartilage is derived from the neural crest of the pharyngeal arches. Each of the 
different cell types in the arch gives rise to distinct structures. Each pharyngeal arch is 
composed of a cylinder of neural crest cells surrounding a core of mesodermal cells. The 
arches are separated from each other by ectoderm-lined pharyngeal clefts and endoderm-
lined pharyngeal pouches (Fig. 1.4). The ectoderm gives rise to sensory neurons while the 
endoderm forms the epithelial lining of the pharynx and the endocrine glands: thyroid, 
parathyroid and thymus. The mesoderm forms the musculature and endothelial cells of 
the arch arteries, and the neural crest forms the connective and skeletal tissues of each 
arch (Graham, 2003; Wurdak et al., 2006).  
While the structure of the arch is conserved, each arch has an individual identity. 
The first arch (mandibular) forms the jaw, the second forms the hyoid apparatus, while 
the posterior (branchial arches) become incorporated into the throat. Neural crest cells 
that populate the pharyngeal arches arise as three streams from different parts of the 
brain. The neural crest cells that fill the first arch, arise from rhombomeres 1 and 2. The 
second arch neural crest cells arise from rhombomere 4. This pattern is common to 
mouse and zebrafish.  The caudal arches are filled by neural crest cells emerging from 
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rhombomeres 6 and 7 in mouse and rhombomeres 6-8 in zebrafish (Graham, 2003; 
Piotrowski et al., 2003) (Fig. 1.4).  
Although neural crest cells carry patterning cues with them, interaction with other 
cell types, particularly the endoderm, is required for correct patterning and formation of 
pharyngeal arches (David et al., 2002; Piotrowski and Nusslein-Volhard, 2000). Initial 
segmentation and expansion of pharyngeal arches and pouches, is followed by 
differentiation to form the mature cartilage. This pattern of development and 
differentiation is largely conserved across species with minor differences; for example 
the endoderm-derived gill clefts persist in fish but not in higher vertebrates. After 
reviewing cartilage development, I will describe what is known about Tbx1’s role in 
cartilage development. 
 
1.6.1   tbx1 and cartilage development 
The tbx1-deficient zebrafish van gogh mutants are characterized by small otic 
vesicles, and reduced pharyngeal skeleton whose elements are often fused. Mutant 
embryos fail to form segmented endodermal pouches, hence abolishing pharyngeal arch 
segmentation. The neural crest cells migrate in distinct streams, but fuse abnormally 
when they reach the pharyngeal arches (Piotrowski and Nusslein-Volhard, 2000). 
Elements of the first and second arches are reduced, while the branchial arches are highly 
reduced or absent. Transplantation of wild-type (WT) endodermal cells partially rescued 
pharyngeal cartilages, implying that neural crest-derived cartilage defects in tbx1
-/-
 
mutants result from defective signaling from the endoderm (Piotrowski et al., 2003).  
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In situ hybridization and transplantation analysis was used to place the genes 
endothelin-1 (edn1) and hand2 in a regulatory pathway downstream of tbx1(Piotrowski et 
al., 2003). edn1 is co-expressed with tbx1 in the mesodermal core, pharyngeal epithelia 
and endodermal pouches. Edn1 is a small diffusible peptide which regulates Hand2, a 
bHLH transcription factor expressed in the neural crest cells (Miller et al., 2000). edn1 
expression is reduced in tbx1
-/-
,  and edn1
-/-
 mutants have malformed cartilage similar to 
tbx1
-/-
. In addition, transplantation of wild-type endodermal cells can partially rescue 
edn1 expression in tbx1
-/-
, suggesting that edn1 functions downstream of tbx1 (Piotrowski 




 mutants and hand2
-
/-
 mutants also have cartilage defects. These results suggest that tbx1 induces the 
expression of edn1, which in turn diffuses and induces hand2 in the neural crest cells 
(Fig. 1.5).  
While edn1 has been identified as a target of Tbx1, it is not clear if it is a direct or 
indirect target. edn1 and other genes in the Edn1 pathway are primarily required for 
correct formation of the mandibular and hyoid arches. The ventral cartilages of mutants 
in these genes are reduced in size, changed in orientation and fused to the dorsal 
cartilages (Kimmel et al., 1998; Piotrowski et al., 1996). On the other hand, all the 
pharyngeal cartilages are affected in the tbx1
-/-
 mutant. The difference in severity of 






 mutants suggests that Tbx1 signals 
differently in the anterior versus posterior arches and that there might be more molecular 
players involved.  
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In this dissertation, I study heart and cartilage defects in the zebrafish tbx1
-/-
 
mutant to identify downstream genes and further elucidate the mechanism of Tbx1 
function. In this thesis I have identified Alcama as a new downstream target of zebrafish 
Tbx1 regulating heart and cartilage development. Using expression analysis and rescue 
experiments, I have demonstrated that Tbx1 regulates Alcama via Wnt11r in the heart 












Figure 1.1  Map of region deleted in DGS patients (blue arrow) and its corresponding 
region on mouse chromosome 16 (pink) 
The genes of the region deleted in DGS patients is highly conserved in 
the mouse genome. The deletions generated in different mouse models are shown in the 
lower part of the figure. The different BACs used for rescue are also depicted. The blue 
bar shows the BAC that rescues cardiovascular defects in Df1/+ and Lgdel/+ mutants. 














Figure 1.2  Tbx1 expression in mouse and zebrafish 
X-gal staining showing Tbx1 expression in E9.5 (A),  E10.5 (B) and E11.5 (C) mouse 
embryos. At each stage, the most caudal area of the pharyngeal endoderm shows the 
strongest Tbx1 expression. (D) is an outline of the pharynx: A, anterior; P, posterior; L, 
left; R, right. Adapted from (Vitelli et al., 2002).  (E) Dorsal view of 27 hpf and (F) 
lateral view of 30 hpf zebrafish larva showing tbx1 expression withing the mesodermal 















Figure 1.3  Zebrafish Heart formation 
Cmlc2 ISH showing cardiomyocyte fusion (18 somites), cone formation (21 somites), 
cone tilting (23 somites) and linear heart tube (24 hpf).  Images are dorsal views with 
anterior to the top. Cardiac jogging begins at 30 hpf and looping is complete at 48 hpf. 
Images are head-on views, with the embryo’s left side to the right of the figure. The 









Figure 1.4  Zebrafish pharyngeal arch and cartilage patterning 
(A) Schematic drawing showing the migration of neural crest cells in three different 
streams from the rhombomeres in the brain to the different pharyngeal arches. Adapted 
from Piotrowski et al. (2003). (B) Lateral view of 30 hpf zebrafish larva showing neural 
crest in green and pharyngeal endoderm in red. E denotes the eye and y the yolk. Adapted 
from Crump et al. (2004). (C) Schematic showing the ventral view of zebrafish larva 
shown in B. (D) Schematic showing cross-section of an individual pharyngeal arch with 
pharyngeal endoderm (red) on both sides. The arch is composed of a cylinder of neural 
crest cells (green) surrounding a mesodermal core (beige) with epithelium (blue) on the 
outside and endoderm on the inside (red). Lateral and ventral views of 5 dpf WT larva 
showing Alcian Blue staining (E, G) and corresponding schematic (F, H) Abbreviation 
used : bh, basihyal; ch, ceratohyal; cb, ceratobranchial; e, ethmoid plate; hs, 
hyosymplectic; m, Meckel’s cartilage; pp, pterygoid process of the palatoquadrate; pq, 
palatoquadrate. Color code used : green, Meckel’s; blue, platoquadrate; red, 
hyosymplectic; yellow, ceratohyal; light blue, interhyal; light green, arches 3-5; grey, 
















Figure 1.5 The Tbx1 pathway regulating pharyngeal arch development 
(A) The Tbx1 pathway is shown schematically within a cross-section of a pharyngeal 
arch. The mesodermal core is colored beige, neural crest green, endoderm red and 
epithelium as blue. (B) The expression of tbx1, edn1 and hand2 in the respective mutants 
in summarized in the table. Adapted from Piotrowski et al. (2003).   
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2.1   Abstract 
DiGeorge syndrome (DGS), a debilitating syndrome characterized by congenital 
heart disease, craniofacial and immune system abnormalities, is the most common 
microdeletion syndrome with a rate of 1 in 4000 live births. The congenital cardiac 
defects in DGS patients predominantly include conotruncal and ventricular septal defects 
and may be caused by abnormal heart looping. DGS is caused by haploinsufficiency of 
the TBX1 gene. However, the molecular pathways underpinning TBX1’s role in heart 
development are not fully understood. Previous work in zebrafish has identified a tbx1
-/-
 
mutant with craniofacial and immune defects similar to DGS patients, but the heart 
defects are not fully characterized. Here we show that zebrafish tbx1
-/-
 mutants have 
defective heart morphology, looping and function. Failure of proper looping is 
accompanied by the lack of proper differentiation of cells derived from PHF and SHF. A 
severe reduction in proliferation and lack of heart cell shape change contribute to 
defective looping and heart cell differentiation. We show for the first time that tbx1 
regulates heart looping and differentiation via wnt11r (wnt11 related), a member of the 
noncanonical Wnt pathway. Moreover, we demonstrate that activated leukocyte cell 
adhesion molecule a (alcama) functions downstream of both tbx1 and wnt11r in zebrafish 
heart development. Our data supports a model whereby heart looping and differentiation 
are regulated by tbx1 in a linear pathway through wnt11r and alcama. 
 
2.2   Keywords 
  tbx1, wnt11r, alcama, heart, DiGeorge 
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2.3   Introduction 
DiGeorge syndrome (DGS) is the most common microdeletion syndrome 
occurring in 1/4000 live births (Oskarsdottir et al., 2004). Approximately 75-80% of 
patients have congenital heart disease with conotruncal defects (Tetralogy of Fallot, 
aortic arch defects, and truncus arteriosus) and ventricular septal defects. Other defects 
include thymic hypoplasia, palate defects and thyroid and parathyroid abnormalities. 
Cardiac defects are the leading cause of mortality, but the underlying molecular 
pathobiology is not well understood. 
Most DGS patients have a 3Mb or a nested 1.5 Mb deletion of chromosome 
22q11 2 which includes the TBX1 gene. Genetically engineered mouse mutants have led 
to the identification of Tbx1 as the gene responsible for cardiovascular and thymic defects 
(Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001). Several 
patients without the chromosomal deletion harbor frame-shift and missense mutations in 
TBX1, strongly suggesting that DGS is caused by haploinsufficiency of TBX1 (Gong et 
al., 2001; Yagi et al., 2003). TBX1 is a member of a group of transcription factors that are 
characterized by the presence of a T-box, a highly conserved DNA-binding region that 
also has a conserved interaction domain for other transcription factors. T-box genes 
mediate transcriptional activation and/or repression and are important for embryonic 
development and differentiation of all three germ layers (Smith, 1997, 1999; Wilson and 
Conlon, 2002). In addition, T-box genes are extremely dose-sensitive and often act in a 
combinatorial or hierarchical fashion (Greulich et al., 2011). Dose-sensitivity of Tbx1 has 
been tested using various mouse hypomorphic and null alleles and transgenics (Liao et 
al., 2004; Lindsay et al., 2001; Xu et al., 2004). While Tbx1+/- mice have a milder 
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phenotype, Tbx1-/- mice have a severe phenotype with single cardiac outflow tract 
(OFT), aortic and pharyngeal arch defects, thymus and parathyroid gland aplasia (Jerome 
and Papaioannou, 2001). Tissue-specific knockdown of Tbx1 in the pharyngeal endoderm 
or mesoderm recapitulates the cardiac defects observed in Tbx1-/- mice and DGS 
patients, making it difficult to isolate the role of Tbx1 in different tissues (Arnold et al., 
2006; Zhang et al., 2006). Though several genes such as Fgf10 have been implicated to 
be in the Tbx1 pathway (Xu et al., 2004), validation and detailed description of their roles 
is lacking and the Tbx1 pathway remains uncharacterized.  
Several genes and pathways, such as Nkx2.5, GATA family and Bone 
Morphogenetic Protein pathway, regulate heart development (Brand, 2003). These 
pathways may be synergistic, hierarchical or antagonistic in function. For example, 
canonical Wnt and Sonic hedgehog signaling have been postulated to operate upstream of 
Tbx1 (Huh and Ornitz, 2010; Liao et al., 2008). However, noncanonical Wnt signaling 
plays an important role in proper heart morphogenesis by inhibition of ?-catenin 
signaling and by mediating its own signaling via protein kinase C and c-jun terminal 
kinase (Brade et al., 2006; Garriock et al., 2005; Gessert et al., 2008; Matsui et al., 2005). 
Wnt11, a noncanonical Wnt member, is required for heart specification and can induce 
expression of cardiac genes in Xenopus explants and noncardiac cells from humans and 
mouse (Belema Bedada et al., 2005; Eisenberg and Eisenberg, 1999; Flaherty et al., 2008; 
Garriock et al., 2005; Pandur et al., 2002; Schneider and Mercola, 2001; Ueno et al., 
2007). Furthermore, mutations in Wnt11 cause cardiac OFT defects such as truncus 
arteriosus, similar to those observed in Tbx1-/- mutants (Zhou et al., 2007). Knockdown 
of Wnt11r, an ortholog of Wnt11 present in Xenopus, resulted in heart morphology 
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defects and cardia bifida in some cases (Garriock et al., 2005). While both Tbx1 and 
Wnt11 signaling have been shown to be important in heart morphogenesis, no link has 
been established to date.  
The pattern of heart development is conserved through evolution. Development 
begins with specification of the bilateral Primary Heart Fields (PHF) in lateral plate 
mesoderm. Subsequent migration towards the midline results in the cardiac crescent and 
later the linear heart tube, at which point the heart starts beating. The tube then undergoes 
jogging, looping and morphogenetic movements to result in the four-chambered heart. 
This is a complex process involving ballooning of the chamber walls, addition of 
cardiomyocytes derived from the Secondary Heart Field (SHF) at the arterial pole and 
formation of septa and valves. Formation of heart chambers is accompanied by 
differential gene expression within the various parts of the heart (Brade et al., 2006; 
Brand, 2003). Cell tracing experiments in mice and chick have established that heart 
myocardium derives from PHF, while SHF contributes to the OFT (Buckingham et al., 
2005). Interestingly, previous studies suggest that Tbx1 is expressed in SHF and that 
Tbx1 positively regulates SHF cell proliferation and contribution to the muscle layer of 
OFT (Chen et al., 2009; Liao et al., 2008; Xu et al., 2004).  
The pattern of heart development is largely conserved in zebrafish. Similar to 
mice and chicken, fusion of PHFs results in a cardiac cone that tilts and elongates to form 
the linear heart tube. Moreover, presence of SHF and its contribution to OFT has been 
recently confirmed in zebrafish (Hami et al., 2011). Zebrafish have a simple two-
chambered heart with a single inflow and outflow tract and looping results in an S-shaped 
heart instead of the four-chambered heart with multiple outlets. The OFT retains the 
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bulbous arteriosus (BA), an accessory chamber equivalent to the conus arteriosus of 
amphibians and reptiles. This structure has been replaced by the pulmonary and aortic 
trunk in mammals and birds. The simpler structure of the heart combined with 
transparency of embryos and availability of a tbx1 mutant, make zebrafish the ideal 
system to study cardiac defects associated with DGS. Here we use the zebrafish tbx1
-/-
 
mutant (Piotrowski et al., 2003) to study cardiac defects associated with DGS and 
identify Tbx1 target genes. We show that tbx1 is required for proper heart looping and 
differentiation of myocardium derived from the PHF and SHF. In addition we provide 
evidence that tbx1 mediates its function at least in part via wnt11r, and its downstream 
gene alcama.  
 
2.4   Materials and methods 
2.4.1   Fish stocks and maintenance 
Fish were maintained at 28.5 
o
C under standard conditions (Westerfield, 2000) 








) mutant lines were a kind gift from Dr Tatjana Piotrowski (Stowers 
Institute of Medical Research, Kansas City, MO) and Dr. Cecilia Moens (Fred 
Hutchinson Cancer Center, Seattle, WA). Homozygous mutants were obtained by 
inbreeding of heterozygous carriers. Tg(cmlc2:EGFP) fish that express green fluorescent 
protein (GFP) in the nuclei of cardiomyocytes under the control of cardiac myocyte light 
chain promoter, were a gift from Dr Joseph Yost (Department of Neurobiology, 
University of Utah).  
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2.4.2   Identification and genotyping of mutants 
tbx1
-/-
 mutants have an A-to-T missense mutation (Piotrowski et al., 2003). 
Mutant embryos were identified by high resolution melting analysis (Zhou et al., 2005). 
DNA was extracted from the tails of stained embryos and PCR was conducted using the 
primers 5’- CACAACTGAAAATCGCCAGCAATC-3’ (forward, 0.2 μM), 5’- 
AATATGGTAAAACTCACCAGTCCT -3’ (reverse, 1 μM) and 5’- 
TTTACCAAAGGCTTCAGAGACTGTAATCCC -3’ (unlabelled probe complementary 
to reverse strand, 1 μM). After PCR, the samples were heated to 94 °C for 2 minutes and 
then cooled to
 
10 °C before melting.
 
LCGreen dye (Idaho Technology) was included in 
the PCR mix and melting analysis was done on LightScanner
TM
 (Idaho Technology). The 
wnt11r
-/-
 mutant was generated by tilling, and has a G-to-T nonsense mutation that 
generates a stop codon at amino acid 94. wnt11r 
-/-
  mutants were identified in a similar 
fashion using the primers 5’- GGTCTGCCAAAAGACCTTCACAG-3’ (forward, 
0.2μM), 5’- TTGGAAATAAATGCGTTTAGACACGGTT-3’ (reverse, 1μM) and 5’- 
TGTTCCCCTATTGATGGACCGAAACTCCT-3’ (unlabelled probe  complementary to 
reverse strand, 1 μM). All the identified WT and mutants were included in the analysis. 
 
2.4.3   Cloning and RNA transcription 
The tbx1 gene cloned in pCS2+, and wnt11r gene cloned in pCMVSport6.1, were 
obtained from ZIRC (Zebrafish International Resource Center). To make sense RNA for 
injection, these plasmids were cut with NotI and XhoI respectively, and in vitro 
transcribed from Sp6 promoter using mMessage Machine kit (Ambion). RNA for alcama 
was made as previously described (Choudhry et al., 2010).  
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2.4.4   Morpholino antisense oligonucleotide and RNA injections 
Morpholino and RNA were dissolved in molecular biology grade water and 
pressure injected into 1-4 cell zebrafish embryos. For RNA rescue experiments, 26 pg of 
tbx1, wnt11r or alcama RNA was injected per embryo. The previously described 
translation blocking morpholino for alcama was used at 1.1 ng per embryo (Choudhry et 
al., 2010).  
 
2.4.5   Tissue labeling procedures 
Whole mount RNA in situ hybridization (ISH) with digoxigenin was performed 
as previously described (Miller et al., 2000). The plasmids for versican and eln2 were a 
gift from Dr Joseph Yost (Department of Neurobiology, University of Utah) and for 
amhc and vmhc from Dr Dean Li (Department of Human Genetics, University of Utah). 
Alcama protein was stained using Zn-5 antibody from ZIRC at 1:500 dilution. A goat 
anti-mouse secondary antibody conjugated with Alexa 555 (Invitrogen) was used for 
fluorescence labeling of cell boundaries. The Isl-1 antibody was a gift from Dr Richard 
Dorsky (Department of Neurobiology and Anatomy, University of Utah) and was used at 
1:100 dilution. Labelling of bulbous arteriosus with DAF-2DA (VWR) was done as 
previously described (Grimes et al., 2006).  
 
2.4.6   Imaging and quantification 
Head-on photographs of 48 hours post fertilization (hpf) larvae were taken on 
Nikon SMZ1000. Dissected hearts and ISH embryos were photographed on a Nikon Y-
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IDP microscope at 20x zoom using Spot software. Confocal images of dissected hearts 
were taken on Olympus FV1000 microscope at 40x zoom. Images of all larvae from the 
same experiment were taken using the same settings and exposure. Cell numbers were 
counted using Imaris software. Measurements for circularity, length and volume were 
done using ImageJ and angles were measured on Adobe Photoshop. Live embryos were 
mounted in 1% low melt agarose and movies of the beating heart were taken with the 
Nikon Y-IDP microscope.  
 
2.4.7   Analysis of cardiac performance 
Movies of beating hearts were imaged as above and analyzed as follows. Heart 
rate was calculated by counting the number of sequential contractions. The widths of 
ventricles/atria at diastole and systole were measured. Shortening fractions were calculated 
as width [(diastole – systole) / diastole]. Stroke volume was determined as previously 
described (Fritsche et al., 2000). The perimeter of the ventricle during diastole and 
systole was outlined on ImageJ and analyzed with a “fit-to-ellipse” algorithm, giving the 
major and minor axes. Volume was calculated using V = 4/3 * ? * a * b2, and the stroke 
volume was obtained by subtracting the volume at systole from volume at diastole. 
 
2.4.8   Paraffin embedding and sectioning  
Seventy two hpf larvae were fixed in 4% paraformaldehyde for 2 days, 
dehydrated in ethanol series and transferred directly to xylene. They were allowed to 
equilibrate for 90 min and then placed in paraffin. Embryos were embedded in disposable 
plastic molds and cooled before sectioning at 5 μm on a Leica RM2155 microtome. Glass 
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slides were heated to 60
o
C overnight, placed in xylenes for 5 min, rehydrated through an 
ethanol series to water, stained with 0.1% toluidine blue, and coverslipped using Cytoseal 
60 (Fisher Scientific). 
 
2.5   Results 
2.5.1   tbx1 is required for proper cardiac looping and  
morphogenesis in zebrafish 
In zebrafish, tbx1 expression starts between 6 to 10 somites in the lateral plate 
mesoderm containing the cardiac progenitors (Fig. 2S1A and (Piotrowski et al., 2003), 
and continues to be expressed in the myocardium as the heart develops (Fig. 2S1B-D). 
By 48 hpf, expression is stronger in the ventricle as compared to the atrium and 
especially strong in the AVC (Fig. 2S4A). TBX1 is a key transcription factor necessary 
for correct cardiac morphogenesis in humans and mice. We tested whether tbx1 plays a 
role in cardiac morphogenesis in zebrafish by using cmlc2 ISH to visualize the 
cardiomyocytes at various developmental stages in the tbx1
-/-
 mutant. The cardiac 
progenitors are correctly specified from the lateral plate mesoderm at 14 somites, migrate 
towards the midline to fuse (21 somites) and form the linear heart tube at 24 hpf in tbx1
-/-
 
mutants. Jogging of ventricle (30-36 hpf) and looping of the heart (36-48 hpf), leads to an 
S-shaped heart in WT embryos (Fig. 2.1A). Defective jogging and looping in tbx1
-/-
 
mutants yields a straight heart (Fig. 2.1A) with variation in severity between larvae. In 
order to quantify this defect, we measured the angle between the longitudinal axes of 








) (Fig. 2.1A, B), demonstrating that tbx1 is necessary for heart 
looping. 
In addition to the looping defect, tbx1
-/-
 mutants have other cardiac morphological 
defects. Mutant ventricles are significantly shorter at 48 hpf (Fig. 2.1C), while atrial 
length is similar between mutants and WT. The ventricle at its widest point is 
significantly wider in the mutant when compared to WT at 48 hpf, (Fig. 2.1D) and 72 hpf 
(Fig. 2S1G). Atrium width differences between mutants and WT are significant at 72 hpf 
(Fig. 2.1E), but not at 48 hpf (Fig. 2S1H). In addition, sections of the heart at 72 hpf, 
reveal that mutant hearts have thinner ventricular walls and fewer cells and larger 
intercellular spaces (Fig. 2S1E, F). Overall our data indicate that tbx1 is necessary for 
heart looping and morphogenesis of both chambers, with a stronger effect in the 
ventricles. 
 
2.5.2   tbx1 is necessary for proper OFT formation and differentiation 
DGS patients and Tbx1-/- mutant mice have defects in OFT such as persistent 
truncus arteriosus and interrupted aortic arch. Hence we studied the OFT in the zebrafish 
tbx1
-/-
 mutants. The zebrafish ventricle ends in a constriction leading to the BA, an 
accessory chamber present in lower vertebrates that is composed of smooth muscle. 
While the width of BA is unaffected (Fig. 2.2A, E, I), it is shorter in tbx1
-/-
 mutants 
versus WT siblings (Fig. 2.2A, E, J). Our analysis revealed that BA smooth muscle in 
tbx1
-/-
 mutants is defective as evidenced by negative staining with the fluorescent nitric 
oxide sensor DAF-2DA (Grimes et al., 2006) (Fig. 2.2B, F). tbx1
-/-
 mutants also fail to 
express the BA-specific marker tropoelastin2 (eln2) at 72 hpf (Fig. 2.2G). These findings 
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suggest that the BA is improperly formed and undifferentiated in tbx1
-/-
 mutants. Since 
cmlc2 staining revealed normal cardiac specification of the PHF, we analyzed the SHF 
that also contributes to the muscle wall of the OFT. Islet-1 (Isl-1) antibody staining 
reveals that tbx1
-/-
 mutants have normal specification of SHF cells (Fig. 2.2H) at 14-
somites. Our results suggest that in the absence of tbx1 signal, SHF cells form but fail to 
differentiate into smooth muscle of the BA.  
 
2.5.3   tbx1
-/-
 mutants have defects in cardiac performance 
Since cardiac defects are the leading cause of mortality in DGS patients, we 
analyzed cardiac function in tbx1
-/-
 mutants. We analyzed movies of beating hearts in live 
embryos at 31 hpf, 48 hpf and 72 hpf. Cardiac contractility was assessed using the 
ventricular and atrial shortening fractions. Mean ventricular shortening fraction was 
unaffected at 48 hpf but was significantly lower at 72 hpf in tbx1
-/-
 mutants (0.160 + 
0.012) compared to WT (0.197 + 0.014) (Fig. 2.3A). Mean atrial shortening fraction was 
unaffected at 48 hpf and 72 hpf (Fig. 2.3B), in keeping with the weaker morphological 
defect in atria. Cardiac output was analyzed as stroke volume. The stroke volume was 10-
20% lower in tbx1
-/-
 mutants but this difference is not significant (p-value > 0.05) (Fig. 
2.3C). This result is surprising considering the severe ventricular morphological defect. 
Heart rate was lower in tbx1
-/-
 mutants. At 48 hpf the mean heart rate decreased to 75% in 
tbx1
-/-
 mutants (108 + 2 beats per minute) as compared to WT siblings (143 + 2 beats per 
minute). At 72 hpf the mutant heart rate (167 + 2) partially recovered to 86% of WT (195 
+ 4) (Fig. 2.3D). This is in contrast to DGS patients where the heart beats faster to 
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compensate for OFT obstructions. In conclusion, the ventricle in tbx1
-/-
 mutants has 
defects in contractility and heart rate. 
 
2.5.4  tbx1 expression is necessary for subspecification of heart regions 
At 48 hpf the heart becomes subspecified to form the various regions: inflow tract 
(IFT), atrium, atrioventricular canal (AVC), ventricle and OFT. In zebrafish, heart 
looping defects are highly correlated with defects in subspecification of the heart, 
suggesting that these regional changes in expression pattern are important for the looping 
process (Auman et al., 2007; Chi et al., 2008; Garrity et al., 2002; Qu et al., 2008; Ribeiro 
et al., 2007; Tu et al., 2009). We performed ISH analysis in tbx1
-/-
 mutants at 52 hpf to 
evaluate if subspecification and differentiation occurs normally. The ventral marker vmhc 
and atrial marker amhc are expressed normally in tbx1
-/-
 mutants, suggesting that atrial 
and ventricular specification occurs normally in tbx1
-/-
 mutants (Fig. 2S2). Bone 
morphogenetic protein 4 (bmp4) is expressed in the IFT, AVC and OFT in WT siblings 
(Fig. 2.4A). Similarly, versican and notch1b are expressed in the AVC myocardium and 
endocardium, respectively (Fig. 2.4B, C).  tbx1
-/-
 mutants fail to express these markers in 
the AVC at this stage (Fig. 2.4E-G). In order to determine if these defects are heart 
specific, we examined versican expression in the otoliths. tbx1
-/-
 mutant otoliths express 
versican (inset Fig. 2.4G), indicating that the defect is heart-specific. Expression of atrial 
natriuretic factor (anf) is restricted to the outer curvature of the ventricle and atrium. 
However anf expression is expanded to the inner curvature in the ventricle and to a lesser 
degree in the atrium in tbx1
-/-
 mutants. The abovementioned markers are expressed 
normally at 30 hpf (data not shown) in the mutants, indicating that the differentiation 
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defect arises during the looping process. In addition, penetrance of these defects is 
variable in tbx1
-/-
 mutant larvae (Fig. 2.4M-P). notch1b showed the highest penetrance 
and we will henceforth use it as a marker for subspecification. Failure of tbx1
-/-
 mutants 
to restrict anf expression, taken together with absence of bmp4, notch1b, and anf, 
suggests that tbx1 is necessary for looping, subspecification and differentiation of heart 
regions.  
 
2.5.5   tbx1 regulates cardiomyocyte proliferation and shape 
The spatiotemporal pattern of cell proliferation is a major contributor to inflation 
of the chambers giving rise to the final looped structure of the heart (Ribeiro et al., 2007). 
Hence a defect in the timing, region or amount of proliferation may lead to looping 
defects. We used Tg(cmcl2:EGFP) larvae to count total cell numbers in hearts, and 
phosphohistone 3 staining to determine the percentage of cells undergoing mitosis (Fig. 
2.5A,B). Total cardiomyocyte number was unchanged at 33 hpf, but was decreased 1.3 
fold at 48 hpf (post-looping and morphological defects) (Fig. 2.5C). This correlates with 
the lower cell density and larger intercellular spaces observed in sections of tbx1
-/-
 mutant 
hearts (Fig. 2S1F). Analysis of phosphohistone 3 staining reveals that the mean number 
of proliferating cells per heart is reduced 1.6 times at 33 hpf (15 in WT siblings versus 9 
in tbx1
-/-
 mutants, Fig. 2.5D), suggesting that the decrease in cell number is due to 
decreased proliferation. In addition to the number, we analyzed the spatial distribution of 
proliferating cells. By 33hpf, proliferating cells become restricted to the chambers 
exclusively, as opposed to even distribution along the heart tube at 24 hpf. We detected 
no defect in this restriction of proliferating cells in mutants (data not shown), suggesting 
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that tbx1 regulates the number but not the spatial distribution of proliferating cells during 
the later stages of heart development (after 30 hpf).  
Cardiomyocyte shape changes are another important element of proper heart 
looping.  The cells transition from small and rounded morphology in the linear heart tube 
(24-28 hpf) to flattened and elongated structures in the outer curvature at the expanded 
chamber stage (48-58 hpf) (Auman et al., 2007).  We stained 48 hpf Tg(cmlc2:EGFP) 
larvae with Alcama antibody to visualize the cell boundary, and analyze cell shape. In 
WT siblings the cells in the outer curvature are elongated with their longitudinal axes 
pointing towards the AVC (white, Fig. 2.5E), while cells in the inner curvature continue 
to be small and rounded (yellow, Fig. 2.5E). However, tbx1
-/-
 mutant cells in the outer 
and inner curvatures retain the small and rounded morphology (Fig. 2.5F). We assessed 
this defect by calculating the circularity of 10 cells from the inner and outer chambers of 
7 larvae. Cells from tbx1
-/-
 mutants in the outer curvature have 1.2-1.3 fold higher 
circularity (are rounder) as compared to WT siblings (Fig. 2.5G), while cells in the inner 
curvature are equally round in between the mutant and WT (Fig. 2.5H). In summary, our 
data suggests that tbx1 is required for maintenance of cardiomyocyte proliferation and 
regulation of cell shape, and thus reduced proliferation and failure to change shape causes 
the looping defect in tbx1
-/-
 mutants.  
 
2.5.6   lox and pdpk1a are new candidates for Tbx1 target genes 
To look for downstream targets and/or interactors of Tbx1 that may mediate heart 
looping defects, we performed a microarray screen. tbx1
-/-
 mutants were identified from 
Tg(cmlc2:EGFP) fish based on the looping phenotype at 52 hpf and their hearts were 
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isolated for RNA extraction. WT sibling hearts were used as controls. Fig. 2.6A shows 
the results from gene ontology analysis of the microarray. As expected, tbx1 functions as 
both a transcriptional activator and repressor. The results for several genes like fibroblast 
growth factor 10 (fgf10) and six1 that are implicated in the tbx1 pathway (Guo et al., 
2011; Xu et al., 2004) are shown in Fig. 2.6B. From our microarray results, we tested 
lysyl oxidase (lox) and 3-phosphoinositide dependent protein kinase-1a (pdpk1a) as they 
were highly down-regulated and were expressed in the heart. We verified that lox and 
pdpk1a are down-regulated in tbx1
-/-
 mutants by ISH analysis (Fig. 2.6C), validating our 
microarray.  
 
2.5.7   tbx1 and wnt11r function in the same pathway to regulate  
heart looping and subspecification 
We extended our survey of new Tbx1 target genes by a candidate approach. T-
Box proteins frequently interact and several among them such as tbx2a, tbx3b (Ribeiro et 
al., 2007), tbx5 (Garrity et al., 2002), and tbx20 (Brown et al., 2005) have been 
implicated in heart looping. wnt11r, a member of the noncanonical Wnt pathway, has 
also been implicated in regulating expression of cardiac markers and heart looping in 
Xenopus (Gessert et al., 2008). While zebrafish wnt11r is homologous to Xenopus 
wnt11r, its role in zebrafish heart development and looping has not been studied so far. In 
order to discriminate which looping pathways are affected in tbx1
-/-
 mutants, we analyzed 
the microarray and performed ISH analysis for these genes. Microarray analysis revealed 
that wnt11r and tbx3b were down-regulated, tbx20 was up-regulated, while tbx2a and 
tbx5 were unaffected. By ISH analysis, all these genes are expressed stronger in the 
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ventricle as compared to the atrium at 52 hpf in WT embryos. While all the tbx genes 
were unaffected in tbx1
-/-
 mutants (Fig. 2.7A-D, F-I), wnt11r expression was down-
regulated in tbx1
-/-
 mutants (Fig. 2.7E, J). This result was corroborated by quantitative 
RT-PCR, which indicates that wnt11r RNA is down-regulated by 37% in hearts of tbx1
-/-
 
mutants (not shown). These data led us to hypothesize that tbx1 regulates heart looping 
via wnt11r.  
To test the hypothesis that tbx1 regulates heart looping and subspecification of 
heart regions via wnt11r, we first analyzed wnt11r expression in zebrafish larvae. The 
expression and role of wnt11r in heart development in zebrafish is unknown. ISH 
revealed that wnt11r is expressed for the first time in cardiac mesoderm just prior to 
fusion (21 somites, Fig. 2S3A). wnt11r continues to be expressed in cardiomyocytes as 
the heart forms and loops, though expression becomes weaker (Fig. 2S3B, C). Next, we 
analyzed the zebrafish wnt11r 
-/-
 mutant (Banerjee et al., 2011). cmcl2 ISH revealed that 
the wnt11r 
-/-
 mutants also have defective heart looping (Fig. 2.8A, B) with the angle 




 in WT 
siblings. Next we tested whether wnt11r 
-/-
 mutants have subspecification defects similar 
to tbx1
-/-
 mutants. ISH analysis revealed that wnt11r 
-/-
 mutants have down-regulated 
bmp4, versican and notch1b and mis-expressed anf (Fig. 2.8C). DAF-2DA and eln2 ISH 
reveal that wnt11r 
-/-
 mutants do not have BA defects (Fig. 2S3D, E), suggesting that the 
heart looping and subspecification defects are independent of BA defects. The 
subspecification defect combined with the looping defect observed in wnt11r 
-/-
 mutants, 
supports our hypothesis that tbx1 and wnt11r function in the same pathway to regulate 
heart looping and subspecification. 
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To further explore this hypothesis we conducted nonallelic noncomplementation 
assays. We crossed tbx1
+/-
 and wnt11r 
+/-
 mutants and analyzed the double heterozygous 




 larvae have incomplete looping and fail to express notch1b in significantly more larvae 
as compared to tbx1 
+/-
 or wnt11r 
+/-
 larvae (Fig. 2.8D). These data suggest that tbx1 and 
wnt11r function in the same pathway to regulate heart looping and subspecification.  
 
2.5.8   tbx1 regulates heart looping and subspecification via  
wnt11r and alcama 
Our data suggests that tbx1 and wnt11r function in the same pathway and down-
regulation of wnt11r in tbx1
-/-
 mutants (Fig. 2.7J) suggests that wnt11r may be 
downstream of tbx1. We tested this by analyzing tbx1 expression in wnt11r 
-/- 
mutants. By 
ISH tbx1 expression is unchanged in wnt11r 
-/-
 mutants as compared to WT siblings (Fig. 
2S4A, C). The nonallelic noncomplementation assay in conjunction with expression 
analysis indicate that wnt11r functions downstream of tbx1 in regulating heart looping 
and subspecification.  
Previous work identified Xenopus alcama as a downstream target of wnt11r 
during differentiation of cardiomyocytes and heart looping (Gessert et al., 2008). This led 
us to extend our hypothesis: tbx1 regulates wnt11r, wnt11r regulates alcama, which in 
turn regulates heart looping and subspecification. We first probed our hypothesis by 
analysis of alcama ISH during heart development. alcama expression starts in the heart 
progenitors at 21 somites and continues on until 4 dpf (Beis et al., 2005; Rohr et al., 
2008). Similar to tbx1 expression, alcama expression is stronger in the ventricle than 
 44 
atrium and is especially strong in the AVC in WT embryos.  AT 48 hpf, alcama 
expression is down-regulated in both tbx1
-/-
 and wnt11r 
-/-
 mutants (Fig. 2S4D, F), 
supporting our hypothesis that wnt11r and alcama are downstream of tbx1. The observed 
down-regulation is stronger in the ventricle while the atrium seems unaffected. To test the 
specific function of alcama during zebrafish heart morphogenesis, we injected a 
morpholino directed against alcama (Choudhry et al., 2010) into zebrafish at the 1-cell 
stage and assessed heart looping and subspecification at 48 hpf. alcama morphants have 
defective heart looping of varying severity (Fig. 2S5B-D), a finding that may be 
explained by dosage differences in morpholino injections. In addition to looping defects, 
alcama morphants have defects in subspecification of the heart as assessed by notch1b 





 mutants, and that alcama is needed for normal heart looping and 
subspecification.  
We further tested whether alcama and wnt11r function downstream of tbx1 by 
injecting wnt11r and alcama RNA into tbx1
-/-
 mutants at the 1-cell stage. Injected 
mutants were assessed for rescue of heart looping (cmlc2 ISH, Fig. 2.9B) and 
subspecification (notch1b ISH, Fig. 2.9E) at 52 hpf. tbx1 RNA was injected as a positive 
control for rescue. Injection of either wnt11r RNA or alcama RNA increases the angle 
between the ventricular and atrial axes to nearly WT levels (18
o





 in uninjected tbx1
-/-
 mutants and 23
o
 in WT) (Fig. 2.9C). Similarly, 
injection of either RNA decreased the percentage of larvae with absent notch1b staining 
(Fig. 2.9F). Partial rescue by RNA injection substantiates our model whereby tbx1 
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regulates wnt11r, wnt11r regulates alcama, which in turn regulates heart looping and 
subspecification (Fig. 2.9G).  
 
2.6   Discussion 
2.6.1   tbx1
-/-
 mutants have defects in heart morphology  
and differentiation 
Tbx1 has been identified as the gene responsible for causing DGS. However, the 
cardiac defects in the zebrafish tbx1
-/-
 mutant have not been characterized so far. Using 
the tbx1
-/- 
mutant, we have demonstrated that tbx1 is required for normal heart 
development, as has been demonstrated in mice. Though tbx1 is expressed in cardiac 
mesodermal progenitors at 14 somites from the commitment stage, cardiogenesis 
proceeds normally in tbx1
-/-
 mutants until the onset of looping. This observation is 
consistent with mouse data, suggesting that tbx1 is not required at the very early stages of 
heart development. Hence we conclude that tbx1 is required for differentiation of 
cardiomyocytes, rather than for their commitment or specification.  
Defective heart looping in tbx1
-/-
 mutants is associated with other morphological 
abnormalities, including a wider and shorter heart with a shortened and undifferentiated 
BA. tbx1
-/-
 mutant hearts also display weaker ventricular contractions and slower heart 
rate. At 33 hpf, the onset of jogging, the number of cardiomyocytes is the same in WT 
and tbx1
-/-
 mutants indicating that proliferation and expansion of cardiomyocytes occurs 
normally until this stage. However, proliferation is decreased in the mutants at this stage 
causing a reduction in the number of cardiomyocytes by 48 hpf. While tbx1 has been 
shown to regulate cell proliferation in mouse SHF (Guo et al., 2011; Xu et al., 2004; 
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Zhang et al., 2006), we are the first to demonstrate its role in regulating cell proliferation 
in PHF. Similarly, cardiomyocytes assume a different shape during heart development, 
and this contributes to looping. In tbx1
-/-
 mutants, the cells in the outer curvature fail to 
assume elongated morphology, remaining small and rounded, similar to cells in the linear 
heart tube. These data indicate that tbx1 is required for induction of morphological, 
proliferative and shape changes that contribute to heart looping.  
Other zebrafish mutants/morphants with looping defects share the observed defect 
in cell proliferation and shape (Auman et al., 2007; Qu et al., 2008; Ribeiro et al., 2007). 
Failure of the cardiomyocytes to change shape taken together with reduction in cell 
number may contribute to looping defects by changing cell-cell interaction behavior. 
Indeed, cross-sections of tbx1
-/-
 mutant hearts reveal an increase in extracellular spaces 
compared to WT siblings. This observation is important, as increased extracellular spaces 
have been observed in wnt11r and alcama morphants in Xenopus (Garriock et al., 2005; 
Gessert et al., 2008). These extracellular spaces might lead to altered cell polarity or 
might be causing the observed lack of change in cell shape or lack of differentiation or 
vice versa. Alternatively, the lack of looping might be causing the defect in cell 
proliferation and shape.  
tbx1
-/-
 mutants have defects in subspecification of the various heart regions. ISH 
stainings for cmcl2, vmhc and amhc, and antibody stainings for S46 and MF20 are normal 
in tbx1
-/-
 mutants, indicating that atrial and ventricular fates are assigned properly in the 
tbx1
-/-
 mutant. However, bmp4, versican and notch1b are down-regulated and anf is mis-
expressed in the tbx1
-/-
 mutants, indicating that cardiomyocytes fail to differentiate into 
the specific regions of the heart such as the OFT. Absent expression of bmp4, versican 
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and notch1b in tbx1
-/-
 mutants is in striking contrast to other looping mutants, where these 
markers fail to get localized to their respective domains (Auman et al., 2007; Qu et al., 
2008; Ribeiro et al., 2007; Tu et al., 2009). Hence we propose that tbx1 has distinct 
functions from other genes involved in heart morphology, such as tbx2a, and nkx2.5. An 
unresolved question is whether subspecification of the heart regions causes looping or 
vice versa. 
T-box genes generally act in combination or in the same pathway (Ryan and Chin, 
2003; Smith, 1999). The presence of heart looping defects in multiple morphants of T-
box genes such as tbx5 and tbx20 suggests that tbx1 might function in conjunction with 
other T-box genes. While our ISH analysis does not support the possibility of these genes 
functioning downstream of tbx1, it is possible that they act combinatorially, in parallel or 
upstream of tbx1. Future analysis of wnt11r and alcama expression in tbx gene depleted 
embryos will help to elucidate tbx gene interations during heart development. 
 
2.6.2   tbx1 regulates differentiation of the SHF and BA 
DGS patients and Tbx1-/- mice have OFT defects such as persistent truncus 
arteriosus. Moreover, Tbx1 is expressed in the SHF and regulates SHF contribution to the 
OFT (Xu et al., 2004). In accordance with mouse data, our data suggest that tbx1
-/-
 
mutants have a smaller BA. In addition, absent eln2 expression and DAF-2DA staining 
indicates that smooth muscle in the BA is undifferentiated. At 14 somites, Isl1-positive 
SHF cells seem unaffected in tbx1
-/-
 mutants, suggesting that SHF is formed properly in 
tbx1
-/-
 mutants, but then fails to differentiate into smooth muscle of the BA. While our 
investigation of the BA defect in tbx1
-/-
 mutants was ongoing, another study identified 
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that absence of tbx1 led to reduced incorporation of SHF-derived arterial pole cells into 
the BA (Hami et al., 2011). These results are in agreement with our data, indicating that 
tbx1 is not required for formation of SHF cells but is required for their incorporation into 
the BA and subsequent differentiation of smooth muscle cells.  
 
2.6.3   wnt11r functions downstream of tbx1  
Though Wnt11 signaling has been shown to be important for specification of 
cardiac fate and Wnt11-/- mutants have OFT defects, Tbx1 and Wnt11 signaling has not 
been linked as yet (Eisenberg and Eisenberg, 1999; Pandur et al., 2002; Zhou et al., 
2007). Unlike mouse and chicken embryos, Xenopus and zebrafish embryos do not 
express wnt11 in the developing heart (Garriock et al., 2005). wnt11r, a second wnt11 
gene in Xenopus and zebrafish, with high homology to human and chicken Wnt11, 
mediates noncanonical Wnt signaling and is necessary for normal heart morphogenesis. 
In Xenopus, wnt11r starts to be expressed just prior to fusion of cardiac progenitors and 
subsequently continues to be expressed in the heart tissue. It was later discovered that 
alcama regulates cardiac looping and functions downstream of wnt11r in Xenopus 
(Gessert et al., 2008). 
In spite of previous work in Xenopus, the role of wnt11r in zebrafish heart 
morphogenesis has not been previously characterized. We have shown that similarly to 
Xenopus, zebrafish wnt11r is first expressed at 21somites just prior to cardiac progenitor 
fusion and continues to be expressed as the heart develops. Our data show that wnt11r is 
down-regulated in tbx1
-/-
 mutant hearts, and that wnt11r 
-/-
 mutants have similar looping 
and subspecification defects as observed in tbx1
-/-
 mutants. Furthermore, our nonallelic 
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noncomplementation assay indicates that tbx1 and wnt11r function in the same pathway. 
Moreover, knockdown of alcama, a gene demonstrated to be downstream of wnt11r, also 
presents with looping and subspecification defects. Importantly, we were able to rescue 
the looping and subspecification defects in tbx1
-/-
 mutants by injection of wnt11r and/or 
alcama RNA. All these data lead us to our working model: tbx1 regulates wnt11r, wnt11r 
regulates alcama, which in turn regulates heart looping and subspecification (Fig. 2.9G).  
We were unable to obtain complete rescue with wnt11r and alcama mRNA injections. 
This might indicate that tbx1 regulates genes other than wnt11r and alcama. This 
interpretation is supported by the fact that wnt11r 
-/-
 mutants do not possess defects in 
BA, suggesting that tbx1 regulates BA morphogenesis via an independent mechanism.  
 
2.7   Conclusion 
In summary, this study demonstrates that zebrafish tbx1-/- mutants have defects in  
heart looping and function. This is the first demonstration that tbx1 regulates 
differentiation of cardiomyocytes derived from both the PHF and SHF. In addition, it is 
the first description implicating tbx1’s role in regulating PHF cardiomyocyte proliferation 
and shape. Importantly, we have identified wnt11r and alcama as a novel members of the 
tbx1 pathway. We show for the first time that wnt11r
-/-
 mutants and alcama morphants 
have heart looping and differentiation defects similar to tbx1
-/-
 mutants. Moreover, these 
defects can be rescued by overexpression of wnt11r and/or alcama in tbx1
-/-
 mutants, 
suggesting that they function downstream of tbx1. Our data supports our model, whereby 
tbx1 regulates heart looping and differentiation via wnt11r and alcama.  
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Figure 2.1. Heart shape and looping defects in tbx1
-/-
 larvae.  
(A) cmlc2 ISH in tbx1
-/-
 mutants and WT siblings at various stages. Cardiac progenitors 
are specified and fuse to form the linear heart tube by 24hpf. By 30-36 hpf jogging of the 
ventricle towards the midline is delayed in tbx1
-/- 
larvae. By 48hpf the heart has finished 
looping in WT forming an acute angle between the axes (green lines), but in tbx1
-/- 
mutants the axes are nearly parallel. White arrows indicate the AVC; a, atrium; v, 
ventricle. The plot in B shows the decreased angles between the ventricular and atrial 
axes in tbx1
-/-
 mutants. The plot in C shows the decreased lengths of the ventricle and 
atrium in tbx1
-/- 
mutants. The plots in D and E show the widths of the ventricles at 48 hpf 
and atriums at 72 hpf in tbx1
-/-
 mutants and WT siblings in the expanded and contracted 
states. WT siblings are represented in green and tbx1
-/-
 mutants in pink. N depicts the 









Figure 2.2. Bulbous arteriosus defects in tbx1
-/-
 larvae.  
Dissected hearts from 72 hpf larvae showing the BA region (A, E) and the corresponding 
image showing staining for Alcama antibody (red) and DAF-2DA (green)(B, F). (C, G) 
tbx1
-/-
 mutants at the same stage have absent eln2 expression. (D, H) 14 somite embyos 
stained with Isl-1 antibody indicate the presence of secondary heart field progenitors in 
tbx1
-/-
 mutants. Black arrows indicate the BA and white arrows the secondary heart field 
progenitors. The plot in I shows that the BA is unobstructed, but its length is reduced in 
tbx1
-/-
 mutants (J); * p-value = 0.0045. N = 13 for all measurements. Bidirectional 











 larvae have defects in heart performance.  
The plot in A shows the defect in ventricular contractility measured as shortening fraction 
[(width at diastole – width at systole)/ width at diastole]. The plot in B shows that atrium 
contractility is unaffected in tbx1
-/- 
larvae. The stroke volume (ventricular volume 
[diastole – systole]) plotted in C is unaffected in tbx1
-/-
 larvae, though the heart rate is 
decreased, shown in D. N = 19 in all experiments. WT siblings are represented in green 
and tbx1
-/-








Figure 2.4. Subspecification defects in tbx1
-/-
 mutants.  
48 hpf larvae stained for region-specific markers (A-H) and their schematic 
representation (I-L). Red lines indicate myocardium, grey lines indicate endocardium and 
blue lines indicate gene expression. bmp4 (OFT, AVC and IFT), notch1b (AVC 
endocardium) and versican (AVC myocardium) expression is downregulated in tbx1
-/-
 
mutants (E-G) as compared to WT siblings (A-C). The insets in C and G show versican 
expression in the ear as a control for ISH. anf expression is localized to the outer 
chambers of the myocardium in WT (D), but is broadly expressed in the ventricle and 
atrium in tbx1
-/-
 mutants (H). Arrows point to the AVC in all panels; v, ventricle; a, 
atrium. The plots in M-P show the penetrance of the phenotype as percentage larvae with 
absent/mislocalized expression of the respective gene. N depicts the total number of 















Figure 2.5. Proliferation and Cell shape defects in tbx1
-/-
 mutants.  
(A, B) Confocal projections of hearts from cmlc2:gfp (all heart cells are green) larvae at 
33hpf stained with phospho-histone 3 antibody (proliferating cells are pink). The heart is 
wider and shorter in the mutant (B) with fewer numbers of proliferating cells (B).  C, Plot 
showing that the total number of cells is equal in WT and tbx1
-/-
 mutants at 33 hpf (C), 
but is decreased at 48 hpf. The decrease in proliferating cell number is at 33hpf is 
quantified in Plot D. N is the total number of larvae represented in the plots. (E, F) 
Confocal projections of hearts from cmlc2:gfp larvae at 48 hpf stained with Alcama 
antibody (red) to demarcate cell boundaries. Cells in the outer chamber (white) are 
elongated and their long axes point towards the AVC in WT (E). However, cells in the 
outer chamber of tbx1
-/-
 mutants continue to be small and rounded (F), much like the cells 
in the inner chamber (shown in yellow). The plot in G shows that cells in the outer 
chamber of tbx1
-/-
 mutants are rounder (circularity tending towards 1) as compared to 
WT. The plot in H shows that the cell shape is unchanged in the inner chamber of tbx1
-/-
 
mutants. Each bar in plots G and H represents data from 70 cells collected from 7 larvae. 





















Figure 2.6. Microarray of tbx1
-/-
 mutant hearts reveals new tbx1 targets.  
(A) Gene ontology results for a microarray of tbx1
-/-
 mutant hearts versus WT sibling 
hearts. (B) Results of the microarray for genes implicated in the tbx1 pathway from 
previous literature. lox and pdpk were chosen by us as new candidate genes from the 
microarray. (C) Lateral views of ISH analysis for lox and pdpk at 48 hpf, showing they 
are downregulated in hearts of tbx1
-/-



















Figure 2.7. Candidate gene analysis for tbx1
-/-
 mutants.  
(A-D and F-I), Whole mount lateral views of 48 hpf larvae stained for known genes that 
affect heart looping. Expression of tbx2a (A, F), tbx3b (B, G), tbx5 (C, H) and tbx20 (D, 
I) was unaffected between WT siblings and tbx1
-/-
 mutants. Dissected hearts from 48 hpf 
larvae show down-regulated expression of wnt11r in the mutant (J) versus WT (E). The 



















Figure 2.8. Looping and subspecification defects in wnt11r 
-/-
 mutants.  
A, cmlc2 ISH showing the looping defect in wnt11r 
-/-
 mutants at 48 hpf. The plot in B 
shows the decreased angles between the ventricular and atrial axes in wnt11r 
-/-
 mutants. 
C shows defect in subspecification of heart regions in wnt11r 
-/-
 mutants similar to those 
seen in tbx1
-/-
 mutants. The plots in D and E show the increased penetrance of looping 
and subspecification defects in double heterozygotes as compared to single heterozygotes 
of tbx1 and wnt11r. Arrows point to the AVC; v, ventricle; a, atrium. Scale bars: 50 μm. 






















Figure 2.9. tbx1 functions through wnt11r to regulate heart looping and subspecification. 
ISH for cmlc2 (A, B) and notch1b (D, E) showing rescue of looping (B) and 
subspecification defect (E) at 48hpf after injection of 26 pf wnt11r RNA at the 1-cell 
stage. Plots in C and D quantify the rescue of looping and subspecification defect after 
the indicated injections. WT siblings are represented in green and uninjected tbx1
-/-
 
mutants in pink, with injected mutants in dark pink or red. Scale bars: 50 μm. N depicts 
the total number of larvae from 3 experiments. The schematic in G shows our working 
model, where tbx1 regulates wnt11r; wnt11r regulates alcama, which in turn regulates 
heart looping and subspecification. tbx1 regulates migration/differentiation of SHF cells 




















Figure 2S1. tbx1 expression and phenotype of tbx1
-/-
 1arvae.  
ISH for tbx1 in WT larvae showing expression in the lateral plate mesoderm (14 somites, 
A), the fusing heart fields (21 somites, B), linear heart tube (24 hpf, C) and the looped 
heart (48 hpf, D). (E,F) 5 micron sections of the hearts from 72 hpf larvae, showing 
absence of looping, wider ventricle and atrium and thinner heart walls in tbx1
-/-
  mutant 
(F) as compared to WT sibling (E). The plot in G shows that the ventricle continues to be 
wider in tbx1
-/-
 larvae at 72 hpf, while the atrium is unaffected at 48 hpf (H) and becomes 



















Figure 2S2. Chambers are specified correctly in tbx1
-/-
 mutants.  
ISH analysis at 48 hpf for vmhc (A, C) and amhc (B, D) shows that the chambers are 
















Figure 2S3. wnt11r expression and unaffected bulbous arteriosus in wnt11r 
-/-
 mutants.  
(A-C) wnt11r ISH showing expression in the fusing heart fields (21 somites, A), linear 
heart tube (24 hpf, B) and fully looped heart (48 hpf, C). (D,E) Lateral and ventral views 



















Figure 2S4. tbx1 regulates alcama levels via wnt11r.  
(A-F) ISH analysis on 48 hpf larvae showing that wnt11r 
-/-
 mutants have unaffected tbx1 
expression (C) but downregulated alcama expression (D) when compared to WT siblings 
(A, B). In addition alcama is downregulated in tbx1
-/-












Figure 2S5. alcama morphants have heart looping and subspecification defects.  
cmlc2 ISH on 48hpf larvae showing the various looping phenotypes observed in alcama 
morphants (B-D) and proper looping in an uninjected larva (A). notch1b is expressed in 
the AVC endocardium in an uninjected larva at 48 hpf (E), but is downregulated in 
alcama morphant (F). Arrows point to the AVC. Scale bars: 50 μm. 
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The zebraﬁsh pharyngeal cartilage is derived from the pharyngeal apparatus, a vertebrate-speciﬁc structure
derived from all three germ layers. Developmental aberrations of the pharyngeal apparatus lead to birth
defects such as Treacher-Collins and DiGeorge syndromes. While interactions between endoderm and neural
crest (NC) are known to be important for cartilage formation, the full complement of molecular players
involved and their roles remain to be elucidated. Activated leukocyte cell adhesion molecule a (alcama), a
member of the immunoglobulin (Ig) superfamily, is among the prominent markers of pharyngeal pouch
endoderm, but to date no role has been assigned to this adhesion molecule in the development of the
pharyngeal apparatus. Here we show that alcama plays a crucial, non-autonomous role in pharyngeal
endoderm during zebraﬁsh cartilage morphogenesis. alcama knockdown leads to defects in NC differenti-
ation, without affecting NC speciﬁcation or migration. These defects are reminiscent of the phenotypes
observed when Endothelin 1 (Edn1) signaling, a key regulator of cartilage development is disrupted. Using
gene expression analysis and rescue experiments we show that Alcama functions downstream of Edn1
signaling to regulate NC differentiation and cartilage morphogenesis. In addition, we also identify a role for
neural adhesion molecule 1.1 (nadl1.1), a known interacting partner of Alcama expressed in neural crest, in NC
differentiation. Our data shows that nadl1.1 is required for alcama rescue of NC differentiation in edn1−/−
mutants and that Alcama interacts with Nadl1.1 during chondrogenesis. Collectively our results support a
model by which Alcama on the endoderm interacts with Nadl1.1 on NC to mediate Edn1 signaling and NC
differentiation during chondrogenesis.
© 2010 Elsevier Inc. All rights reserved.
Introduction
Formation of the pharyngeal apparatus is a crucial part of
vertebrate development because it gives rise to the cartilage,
connective tissue, sensory neurons, thyroid, parathyroid and thymus.
Defects in this process results in human birth defects such as DiGeorge
and Treacher-Collins syndromes. Generation of this tissue is highly
complex, involving extensive cell migration and signaling between
cells derived from all three germ layers. NC cells migrate from the
dorsal neural tube in three distinct streams into a series of pharyngeal
arches and eventually give rise to cartilages and bones of the head.
Each pharyngeal arch is composed of a cylinder of NC surrounding a
mesodermal core. The NC is covered by ectoderm on the outside and
endoderm on the inside. Between the arches, endoderm meets
ectoderm forming the pharyngeal pouches, which later develop into
gill clefts and the epithelial lining of the pharynx, thyroid, parathyroid
and thymus (Graham, 2003).
Though NC cells carry intrinsic cues for patterning (Noden, 1983),
they receive extrinsic cues from the surrounding cells and extracellular
matrix as they migrate. Recently, the endoderm has been found to
contribute signiﬁcantly to NC development. Ablation and extirpation
experiments in chicken have revealed that the endoderm carries
patterning information for theNC in segments along the antero-posterior
andmedio-lateral axis (Couly et al., 2002; Ruhin et al., 2003). In addition,
genetic mutants in zebraﬁsh have also revealed the requirement of
endoderm in formation of cartilage. The sox32-deﬁcient casanovamutant
lacks endodermal pouches and cartilages that are rescued by wild-type
endodermal transplants (David et al., 2002). Likewise, the tbx1-deﬁcient
van goghmutant fails to form segmented endodermal pouches resulting
in fusion of the pharyngeal cartilages (Piotrowski and Nusslein-Volhard,
2000). Similarly, the zebraﬁsh mutant for integrinα5 lacks the ﬁrst
endodermal pouch and the anterior part of the hyoid cartilage (Crump
et al., 2004). Although these data demonstrate that endoderm is essential
for cartilage development, the cellular and molecular interactions
between the NC and endodermal cells are not fully understood.
One major signaling factor that provides an extrinsic cue
regulating NC differentiation is endothelin-1 (edn1). edn1 is expressed
in the mesodermal cores, ectoderm and endoderm of the pharyngeal
arches, but not in NC. Edn1 signals the NC and induces ventralization
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of pharyngeal arch cartilage (Miller et al., 2000). Mutations in edn1,
Edn1 cleaving enzymes and other genes in the Edn1 signaling cascade
(sucker, schmerle, hoover and sturgeon) cause similar cartilage defects,
and have been placed in the same class (Kimmel et al., 2001;
Piotrowski et al., 1996). Typically, the ventral domains of the ﬁrst two
arches are reduced in size, changed in orientation, and fused with the
dorsal domains, while the posterior arches are mostly unaffected.
Hence, Edn1 is an important signaling factor that is required non-
autonomously for NC differentiation into cartilage.
Other molecular players that may signal from endoderm to NC
remain elusive. While Alcama is commonly used as a marker for
pharyngeal endoderm in zebraﬁsh (Crump et al., 2004; Piotrowski and
Nusslein-Volhard, 2000), its role in this tissue has not been elucidated
thus far. In zebraﬁsh, Alcama has been studied primarily for its role in
neurogenesis (Diekmann and Stuermer, 2009; Fashena and
Westerﬁeld, 1999). Initially identiﬁed in chicken for its role in neurite
extension (Burns et al., 1991), ALCAMA has now been shown to be
involved in axonal pathﬁnding and axonal fasciculation (Diekmann
and Stuermer, 2009; Weiner et al., 2004). Its non-neuronal roles
include T-cell activation (Bowen et al., 2000; Fashena and Westerﬁeld,
1999; Ofori-Acquah and King, 2008; Zimmerman et al., 2006),
metastasis (Degen et al., 1998; Ofori-Acquah and King, 2008) and
cell migration (Heffron and Golden, 2000). Human ALCAM is a
transmembrane glycoprotein having ﬁve Ig domains, a transmembrane
domain and a short cytoplasmic tail. It mediates cell-cell clustering
through homophilic (ALCAM-ALCAM) as well as heterophilic
(ALCAM-NgCAM and ALCAM-CD6) interactions (DeBernardo and
Chang, 1996; Degen et al., 1998). While ALCAM can activate signal
transduction pathways in neighbouring cells through heterophilic
interactions (Ibanez et al., 2006), a non-autonomous role of ALCAM has
not been deﬁned thus far. In this paper we demonstrate that zebraﬁsh
Alcama, expressed in the pharyngeal endoderm, is an important
non-autonomous molecule for NC differentiation. In addition, we
provide evidence that Alcama mediates Edn1 signaling from the
endoderm to the NC by interacting with Nadl1.1 (NgCAM in chicken)
on the NC cells. These data for the ﬁrst time link Alcama to Edn1
signaling and identify a role for the molecular interaction between
Alcama and Nadl1.1 in cartilage formation.
Materials and methods
Fish stocks and maintenance
Fish were maintained at 28.5 °C under standard conditions
(Westerﬁeld, 2000) and were staged as described (Kimmel et al.,
1995). The suckertf216b mutant (edn1−/−) line was obtained from
Zebraﬁsh International Resource Center (Miller et al., 2000). Homo-
zygous mutants were obtained by inbreeding of heterozygous
carriers. Tg(ﬂi1:EGFP) ﬁsh have been previously described (Lawson
andWeinstein, 2002). Alcian Blue stained larvae of furina−/−mutants
at 5 days post fertilization (dpf) were a kind gift from Chuck Kimmel
(Institute of Neuroscience, University of Oregon).
Identiﬁcation and genotyping of edn1−/− mutants
edn1−/− mutants have an A-to-T missense mutation (Miller et al.,
2000). The mutants were identiﬁed by Derived Cleaved Ampliﬁed
Polymorphic Sequences assay (Neff et al., 1998). DNA was extracted
from the tails of stained embryos and PCR was conducted using the
primers 5'-AGATGCTCCTGCGCAAGTTTTCTAG-3' and 5'-CTGACT-
TACTCTGGTGTGTTCACCC-3'. The mismatch in the primer which
introduces a XbaI site in the wild-type (WT) but not in the mutant
is underlined. The 93 bp PCR product, when digested with XbaI, gives
a 68 bp product in WT. The 93 and 68 bp products were resolved on a
4% Metaphor agarose gel (Lonza). All the identiﬁed WT and mutants
were included in the analysis.
Cloning and RNA transcription
RNA extracted from48 h post fertilization (hpf) Tü larvaewas used
for cDNA synthesis. PCR for alcama was performed using the forward
primer 5'-ggatccgccaccATGCATTCGGTTATCTGCCTTTTCG-3' with a
BamHI and Kozak overhang and the reverse primer 5'-ctcgagTTAGA-
CATCTGCTTTATGATTGTTCTCCTCC-3' with a XhoI overhang. The over-
hangs are shown in lower case. The PCR product was cloned into
pCMV-Script using TOPO TA kit (Invitrogen). The edn1 cDNA clone in
pBK-CMV was obtained from ZIRC.
To make sense RNA for injection, the edn1 and alcama plasmids
were cut with KpnI and in vitro transcription was driven from the T3
promoter using mMessage Machine kit (Ambion). ednrb1 was cloned
from cDNA into TOPO TA using the primers 5'-ATGCGTTTCCAAAT-
TATTATGGAAACAAGATGCG-3' (forward) and 5'-TCAGTGCCTAATTT-
GAAGTATACTTGTTGGAGAC-3' (reverse) and this plasmid was used to
make ISH probe.
Morpholino anti-sense oligonucleotide and RNA injections
Translation blocking (TB) and splice site blocking (SB) Morpho-
linos (MOs) were designed to bind 143 bp upstream of the
transcription start site and at the donor site of exon 6 alcama
mRNA, respectively. alcama blocking and control MO were purchased
from Gene Tools, Inc. The sequences are TB MO: 5'-GTTCTCCTTTATA-
CAGTCCGGCGAC-3'; SB MO: 5'-GCAGTCCCTCACCTTAATGTTAAAG-3';
control MO: 5'-TGATCACCTGCAGATGGACGCTGCG-3'. The optimal
doses were determined to be 1.1 ng for the TB MO and 2.2 ng for
the SB MO. The control MO was injected at 1.1 ng per embryo. The TB
MO for nadl1.1: 5-'CAGGCTGACTCTGCACTGGAGGCAT-3' has been
previously described (Wolman et al., 2007) and was injected at 4.4 ng
per embryo. 26 pg of alcama or edn1 RNA was injected per embryo.
MOs and RNA were dissolved in molecular biology grade water and
pressure injected into one to four cell zebraﬁsh embryos. For
suboptimal doses, the alcama TB MO was used at 0.5 ng and the
nadl MO at 1.1 ng per embryo.
Treatment with proteasome inhibitor MG-132
MG-132 was dissolved in DMSO at a stock concentration of
500 mM. Embryos were dechorionated at 5 hpf and transferred to E2
with 50 μM MG-132 (Bretaud et al., 2007) or with 1% dimethyl
sulfoxide (DMSO). MG-132- and DMSO-treated control larvae were
ﬁxed at 30 hpf and stained.
Tissue labeling procedures
Alcian Blue cartilage staining and dissection were performed as
described (Kimmel et al., 1998). Whole mount RNA in situ
hybridization (ISH) with digoxigenin was performed as described
(Miller et al., 2000). The plasmids for dlx2a, dlx3b, dlx5a were a kind
gift from Gage DeKoeyer Crump (Keck School of Medicine, University
of Southern California). The plasmid for nadl1.1 was a gift fromGavin J
Wright (Cell Surface Signalling Laboratory, Wellcome Trust Sanger
Institute). Alcama protein was stained using Zn-5 antibody from ZIRC
at 1:500 dilution. A goat anti-mouse secondary antibody conjugated
with Alexa 555 (Invitrogen) was used for ﬂuorescence quantiﬁcation
purposes. DAPI staining was used for counting the number of cells in
the pouches.
Imaging and quantiﬁcation
Skeletons and ISH embryos were photographed on a Nikon Y-IDP
microscope at 20× zoom using Spot software. Confocal images of
antibody stained embryos were taken on Olympus FV1000 micro-
scope. Images of all larvae from the same experiment were taken
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using the same settings and exposure. Cell numbers were counted
using Imaris software and ﬂuorescence intensity of each z-sectionwas
measured using ImageJ. For immunohistochemistry coupled to ISH,
the secondary antibody conjugated to alkaline phosphatase (Bio-Rad)
was used with Fast Red for detection (Sigma-Aldrich). Fluorescent
ISH was performed following immunohistochemistry as described
(Welten et al., 2006).
Results
alcama is necessary for ventral cartilage formation
We tested whether alcama plays a role in cartilage morphogenesis
by injection of two different MOs: one blocking translation (TB MO),
and the other blocking splicing of exon 6 (SB MO; Fig. 1A). Staining
with Zn-5 antibody, which recognizes Alcama, revealed effective
knockdown of Alcama protein by both MOs (Fig. 1C–E). 5 dpf alcama
morphants are characterized by a protruding lower jaw, cardiac
edema and absence of swim bladder (Fig. 1G). The jaw is shorter in
the antero-posterior (A-P) direction and the ventral elements of the
anterior arches, Meckels (mc) and ceratohyal (ch), are bent ventrally
leading to the protruding lower jaw (Fig. 1I). Injection of the TB MO
consistently leads to a more pronounced phenotype than the SB MO.
Therefore, in subsequent experiments we use the TB MO exclusively
and refer to it as alcama MO.
To eliminate the possibility that the jaw defect is caused by non-
speciﬁc MO-induced p53-activation (Robu et al., 2007), alcamaMO was
injected into the p53 (I166T)mutant line (Parant et al., 2010). Alcian blue
staining of 5 dpf larvae revealed that the percentage of individuals with
affected cartilage was equivalent in wild-type (WT) and the p53−/−
mutant lines (Fig. S1). The speciﬁcity of thephenotypewas also tested by
co-injection of alcama MO and alcama RNA. alcama RNA can rescue the
ventral cartilage defect caused by alcama knockdown (Fig. S1). This
indicates that the cartilagedefect is causedby alcamaknockdownandnot
by off-target MO effects and that alcama is required for the proper
formation of anterior ventral cartilages in zebraﬁsh.
Fig. 1. alcama morphants have defects in facial skeletal patterning. (A) Graphic representation of alcama RNA illustrating the position of TB and SB MOs. (B) Nomarski image of a
48 hpf WT larva with the box indicating the region shown in (C)–(E). 48 hpf control (C), alcama TB (D), and alcama SB (E) morphants stained with Zn-5 antibody. Both MOs
effectively knock down alcama expression in the heart (arrowheads) and pouches (arrows). (F, G) Lateral views of 5 dpf larvae injected with control and alcama TB MOs. alcama
morphants have a protruding jaw (arrows), cardiac edema (arrowheads) and an absent swim bladder (open arrows). Lateral views of Alcian blue-stained control (H) and alcama
(I) morphants at 5 dpf. The line indicates the length of the pharyngeal cartilage, which is shortened in alcama morphants. The arrow points to Meckels cartilage, which is bent
ventrally in alcama morphants. Scale bars: 50 μm.
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Cartilage defects in alcama morphants are reminiscent of the edn1-class
of mutants
In alcama morphants the pharyngeal skeleton is shorter in the
antero-posterior direction and the anterior arch ventral cartilages (mc
and ch) point ventrally rather than anteriorly (Fig. 1H, I). In addition,mc
and ch are fused to their respective dorsal elements, palatoquadrate
(pq) and hyosymplectic (hm) (Fig. 2A, C). The posterior arches are
shorter in the antero-posterior direction, but are otherwise unaffected
(Fig. 1I). To identify the pathway affected in alcama morphants, we
compared the jaw phenotype in alcama morphants to previously
described cartilage mutants. The three characteristic phenotypes of the
ventral cartilages in alcama morphants; shortening, change of orienta-
tion and fusion to dorsal cartilages, are typical of the edn1-class of
mutants (Piotrowski et al., 1996;Walker et al., 2006, 2007). Particularly
striking is the similarity of alcama morphants to furinA−/− mutants
(Fig. 2C, E). This observation suggests that alcama and edn1 may be in
the same genetic pathway.
edn1 regulates alcama protein levels in the pharyngeal pouches
In order to test if an epistatic relationship exists between alcama
and edn1, we analyzed edn1 expression in alcama morphants. While
alcama is also expressed in the heart, retina and the brain (Fig. S2A),
expression of edn1 and alcama coincides in the ventral pharyngeal
area from 18 to 36 hpf (Thisse and Thisse, 2004, 2005). By 30 hpf edn1
expression is clearly demarcated in the mesodermal cores and surface
ectoderm of pharyngeal arches in addition to the pharyngeal pouches
(Miller et al., 2000). At that stage, alcama is expressed in pharyngeal
pouch endoderm (Kopinke et al., 2006). edn1 expression is unchanged
between control and alcamamorphants, suggesting that edn1may act
upstream of alcama (Fig. 3A, B).
To test this possibility, we analyzed Alcama protein expression in
pharyngeal pouches of edn1−/− mutants. 30 hpf larvae were co-
stained with Zn-5 Alcama antibody and DAPI (Fig. 3C, D). Confocal
images were cropped to individual endodermal pouches and
analyzed. Alcama intensity in individual pouches of edn1−/−mutants
was down-regulated to less than 40% of the WT individuals (Fig. 3E).
The total number of Alcama-expressing cells in each pouch (deter-
mined by DAPI staining) is comparable between WT and edn1−/−
mutants (Fig. 3F), indicating that endodermal pouch tissue is present
in edn1−/−mutants, but it expresses reduced amounts of Alcama. This
observation suggests that edn1 possibly regulates Alcama levels in
pharyngeal pouches.
Edn1 is produced as a proprotein, which is cleaved twice to
produce a diffusible 21-amino acid peptide. The peptide acts by
binding to endothelin receptors (Ednr) coupled to G proteins. In
zebraﬁsh, two Ednrs exist; EdnrA and EdnrB. Previous ISH studies
Fig. 2. alcamamorphants have cartilage defects similar to the edn1 class of mutants. Flatmounts of mandibular and hyoid cartilage from 5 dpf Alcian Blue-stained larvae (A, C, E, G);
corresponding schematics (B, D, F, H). The joint between Meckel's and palatoquadrate is fused in alcamamorphants and furinA−/− and edn1−/−mutants. Similarly, the interhyal is
absent in alcama morphants and furinA−/− mutants leading to a fusion of the ceratohyal and hyosymplectic cartilages. alcama morphants and furinA−/− mutants have misshapen
Meckel's cartilage and ceratohyal, but edn1−/− mutants have the most severe defect with a lack of ceratohyal and severely misshapen Meckel's cartilage. DV joint regions are
indicated with arrows in A and B. Fusions at joints are indicated with asterisks in (C)–(H). Cartilages are labeled as followed: pq (palatoquadrate), mc (Meckel's cartilage), hm
(hyomandibula), ch (ceratohyal), sy (symplectic), and ih (interhyal). Scale bar: 50 μm.
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have revealed that ednrA1 and ednrA2 are expressed almost
exclusively in the NC of pharyngeal arches (Nair et al., 2007). We
cloned ednrb1 and validated that this receptor is expressed diffusely
throughout the endoderm and NC (Fig. S2B). ednrb1 expression in the
endoderm is compatible with our hypothesis that Edn1 signals to the
endoderm to regulate Alcam levels.
To corroborate our hypothesis that edn1 regulates Alcama levels,
we tested whether edn1 over-expression could rescue Alcama levels
in edn1−/−mutants. edn1 RNA was injected into edn1−/− embryos at
the 1-cell stage and Alcama protein levels were quantiﬁed at 30 hpf as
discussed previously with one modiﬁcation. The ﬂuorescence inten-
sity of Zn-5 staining in the pharyngeal area from the ﬁrst to the third
pouch, instead of single pouches, was measured and normalized to
uninjected WT (Fig. S3). alcama RNA was injected as a positive
control. edn1 RNA injection results in more than 50% increase in
Alcama protein in WT and edn1−/−mutants (Fig. 3G), suggesting that
edn1 regulates Alcama levels in the endoderm.
Additionally, we investigated the mechanism by which Edn1
regulates Alcama. ISH studies revealed that alcama RNA levels, while
slightly down-regulated in edn1−/− mutants (Fig. S2C, D), do not
explain the severe down-regulation observed in Alcama protein levels
(Fig. 3D, E). This observation suggests that edn1 does not regulate
Alcama levels via regulating transcription. Previous studies have
indicated that edn1 may lead to Snail and β-catenin protein
Fig. 3. Edn1 regulates Alcama levels. edn1 is expressed in the mesodermal cores (arrowheads) of the ﬁrst three arches and in pharyngeal pouches 2–4 (dotted lines) (A). Its expression is
unchanged inalcamamorphants (B). Cropped image of a singlepharyngeal pouch from30 hpfWT sibling (C) and edn1−/−mutant (D) stainedwith Zn-5 (anti-Alcama) antibody in red and
DAPI in blue. (E) Bar graph showing the difference in total Alcama protein in a pouch (second or third pouch), represented as measured ﬂuorescence intensity normalized to WT;
*p-valueb0.0001bya two-tailed t-test. The bar graph in (F) shows the total numberof cells per pouch isunchanged inWTand edn1−/−mutants; **p-value=0.08495bya two-tailed t-test.
n=14 forWT; n=11 for edn1−/−mutants for this experiment whichwas repeatedwith similar results. (G) edn1 regulates the Alcama levels in pouches. The bar graph shows the sum of
Alcama intensity in the ﬁrst three pouches of 30 hpf edn1−/− (green) andWT (red) larvae after the indicated injections (p-valueb0.0001 by one-way analysis of variance). (H) Bar graph
showing the sum of Alcama intensity in the ﬁrst three pouches of 30 hpf edn1−/− larvae after treatment with DMSO or the proteasome inhibitor MG-132; ***p-value=0.0009 by a two-
tailed t-test. N is the number of larvae in a single experiment, which was repeated with similar results. a1 and a2 label pharyngeal arches 1 and 2. Scale bars: 50 μm.
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stabilization by regulating the proteasome pathway (Rosano et al.,
2005; Sato-Jin et al., 2008). To test whether Edn1 stabilizes Alcama
protein by interfering with its degradation by the proteasome, we
treated edn1−/− larvae with the proteasome inhibitor MG132 and
measured Alcama levels. The ﬂuorescence intensity was normalized
to DMSO-treated edn1−/− mutants. Alcama levels in the pharyngeal
pouches increased by more than 300% upon treatment with MG-132
(Fig. 3H), indicating that inhibition of proteasomal degradation is
involved in Edn1-induced regulation of Alcama. While edn1 RNA
injection increases Alcama levels in the pharyngeal pouches, Alcama
levels are unchanged in the heart and retina, where Edn1 signaling is
not active (data not shown). These experiments indicate that Edn1
stabilizes Alcama levels speciﬁcally in the pharyngeal endodermal
pouches by inhibiting some component of the proteasome pathway.
alcama is required for edn1-dependent differentiation of NC
We have determined that alcama morphants have defects in
ventral cartilages. Since cartilage is formed from NC in the pharyngeal
arches, we investigated whether alcama knockdown caused a defect
in the patterning or speciﬁcation of NC. We injected alcama MO into
Tg(ﬂi:EGFP) line which labels NC cells. Analysis of larvae at 30 hpf, a
stage at which the cranial NC has already populated the arches,
revealed that NC migration is unaffected in alcama morphants (Fig.
S4B). This observation was corroborated by ISH with the NC marker
distalless 2a (dlx2a) at the same developmental stage, showing normal
patterning of NC (Fig. S4D). In addition nkx2.3 expression in
endoderm (Fig. S4F), and edn1 expression in mesodermal cores and
endodermal pouches (Fig. 3B) is unaffected in alcama morphants,
suggesting that NC, endoderm and mesoderm are all patterned and
speciﬁed correctly in the pharyngeal region of alcamamorphants. This
result implies that similarly to genes in the Edn1 pathway, Alcama is
not required for NC migration or speciﬁcation, but is involved in a
later stage of cartilage morphogenesis.
Our data suggest that Alcama functions downstream of Edn1 in
cartilage formation. To assess the functional importance of alcama in
the Edn1 signaling pathway, we analyzed the expression of genes
downstream of edn1 in alcamamorphants. Edn1 signaling is required
for the expression of Dlx and Hand2 transcription factors in NC (Miller
et al., 2000; Walker et al., 2006). Like Edn1, Hand2 is required for
ventral cartilage formation and Dlx factors pattern the dorso-ventral
axis of pharyngeal arches (Depew et al., 2002; Miller et al., 2003). In
alcama morphants, the expression of hand2, dlx3b, dlx5a and dlx6a is
strongly reduced in the ﬁrst and the posterior arches, and mildly
reduced in the second arch at 30 hpf (Fig. 4B, E, H, K). Although hand2
expression recovers by 48 hpf, dlx genes continue to be down-
regulated (Fig. S5). At 30 hpf, hand2 expression is down-regulated in
NC, but unaffected in the heart of alcama morphants (Fig. 4B) and
edn1−/− mutants (Fig. 4C), indicating that Alcama is required
speciﬁcally for edn1-dependent expression of NC genes.
edn1-dependent bapx1 expression in the intermediate region of
the precartilage arch is required for cartilage joint formation (Miller et
al., 2003). Consistent with the joint fusion observed in alcama
morphants, bapx1 expression in the intermediate region of arch1 is
down-regulated in alcama morphants (Fig. 4N). Down-regulation of
Edn1-dependent genes in alcama morphants is similar to, but less
severe than that observed in edn1 mutants (Fig. 4C, F, I, L, O). This
observation is consistent with the less severe jaw defect observed in
alcama morphants when compared to edn1 mutants. Taken together
these data suggest that Alcama is required for Edn1-dependent NC
differentiation and the proper formation of ventral cartilage and jaw
joint.
Our data suggests that NC is patterned and speciﬁed correctly in
alcamamorphants (Fig. S3). Hence, the failure of NC to express edn1-
dependent genes that come on later in development, suggests that
alcama knockdown causes a defect in NC differentiation. In subse-
quent experiments, dlx5a expression is used as a marker for NC
differentiation due to its robust expression. The speciﬁcity of MO-
induced NC differentiation defect was tested by co-injection of alcama
MOwith alcama RNA, and by alcamaMO injection in p53−/−mutants
(Robu et al., 2007). dlx5a expression was categorized as strong (all
arches stained), partial (all arches stained but weaker) and absent
(most arches missing staining and some with very weak staining)
(Fig. S6A–C). Co-injection of alcama RNA with alcama MO decreases
the number of affected individuals (absent dlx5a staining) to WT
levels (Fig. S6D), suggesting that the NC differentiation defect is
caused speciﬁcally by alcama knockdown. The percentage of affected
larvae is similar in WT and p53−/−mutants (Fig. S6D), indicating that
similar to the cartilage defect, the NC differentiation defect is caused
by alcama knockdown and is not dependent on off-target MO effects.
alcama over-expression can rescue NC differentiation defect in edn1−/−
mutants
Our data suggests that edn1 regulates Alcama levels and
knockdown of either gene results in a NC differentiation defect. We
tested our hypothesis that edn1 affects NC differentiation via Alcama,
by over-expressing alcama in edn1−/−mutants followed by analysis of
NC differentiation. We injected alcama RNA into edn1−/− mutants at
the one-cell stage and assessed dlx5a expression at 30 hpf as a marker
for NC differentiation. dlx5a staining was classiﬁed as absent, partial
and strong (Fig. 5A–C) and the number of larvae in each categorywere
counted. edn1 over-expression was used as a positive control,
resulting in a 300% increase in the number of edn1−/− mutants with
dlx5a staining (sum of strong and partial) (Fig. 5D). alcama RNA
induces similar increases of rescued edn1−/− mutants as edn1 RNA,
although full rescue of dlx5a expression was not achieved. This
indicates that Alcama functions downstream of Edn1 to regulate NC
differentiation. To bolster this hypothesis, we asked if edn1 rescue of
edn1−/− mutants could be abrogated by alcama knockdown. Indeed,
co-injection of alcamaMO abrogates the ability of edn1 RNA to rescue
dlx5a staining in edn1−/− mutants (Fig. 5D), supporting our previous
ﬁnding that alcama expression is necessary for Edn1 function.
Injection of either edn1 or alcama RNA was unable to rescue the
cartilage defect of edn mutants at 5 dpf, possibly due to dilution of
RNA in rapidly dividing cells.
As opposed to edn1−/− mutants, less than 5% of WT larvae have
absent dlx5a expression. alcama or edn1 RNA injections into WT
embryos do not affect dlx5a expression (Fig. 5E), demonstrating that
these genes do not negatively affect NC differentiation when they are
over-expressed. Co-injection of edn1 RNAwith alcamaMO results in a
similar percentage of larvae with absent dlx5a staining to that
observed in alcama morphants (Fig. 5E). However, there are more
larvae with strong dlx5a expression, suggesting that edn1 may
regulate NC differentiation by another parallel pathway independent
of alcama. In aggregate, these data provide evidence that Alcama
functions downstream of Edn1 in regulation of NC differentiation.
Nadl1.1 mediates Alcama differentiation signal to the NC
Since Alcama is expressed in the endoderm, we investigated the
possibility that it interacts with another protein to mediate Edn1-
signaling to the adjacent NC. Nadl1 (Ng-CAM in chick) has been
shown to interact with Alcama in the chick brain to promote neurite
extension (DeBernardo and Chang, 1996). Zebraﬁsh have two
orthologs of Ng-CAM, nadl1.1 and nadl1.2, but only nadl1.1 is
expressed in the NC (Figs. 6A and 7A). To test if nadl1.1 is involved
in cartilage development, we used a previously described TB MO
targeting nadl1.1 (Wolman et al., 2007). Phenotypically, nadl1.1
morphants are similar to alcama morphants: by 5 dpf they have a
protruding lower jaw, cardiac edema and absent swim bladder (data
not shown). Similar to alcamaMO, nadl1.1MO affects edn1-dependent
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gene expression: hand2 and dlx5a expression is strongly reduced in
the arches with a more pronounced effect on the posterior arches
(Fig. 6B–E). Alcian blue staining reveals cartilage defects reminiscent
of alcama morphants: mc and ch are changed in orientation and are
fused to pq and hm, respectively (Fig. 6G–H'). Injection of nadl1.1MO
into p53−/− mutants yields similar percentages of larvae with dlx5a
down-regulation and jaw abnormalities (Fig. 6F, I), indicating that the
observed effect is speciﬁc to nadl1.1 knockdown. These data suggest
that nadl1.1may be another player in the Edn1 signaling pathway that
regulates ventral cartilage formation.
We investigated the possibility that nadl1.1 is another downstream
effector of Edn1-mediated NC differentiation and cartilage morpho-
genesis that functions independently of Alcama. nadl1.1 expression is
not down-regulated in edn1−/−mutants as compared to WT at 30 hpf
(Fig. S2E, F), indicating that edn1 does not regulate nadl1.1 at the
transcriptional level. Hence, it is unlikely that nadl1.1 functions in the
Fig. 4. alcama is required for edn1-dependent gene expression. Ventral views of larvae at 30 hpf (A–C), and lateral views at 30 hpf (D–L) and at 48 hpf (M–O) respectively. ISH for
hand2 (A–C), dlx3b (D–F), dlx5a (G–I), dlx6a (J–L), and bapx1 (M–O) in control and alcamamorphants and in edn1−/−mutants. hand2, dlx3b, dlx5a and dlx6a expression is strongly
reduced in the ﬁrst and branchial arches and moderately reduced in the second arch in alcamamorphants. Their expression is strongly reduced in all arches in the edn1−/−mutants.
bapx1 expression in the ﬁrst arch intermediate domain is moderately reduced in alcamamorphants and strongly reduced in edn1−/−mutants. a1 and a2 label pharyngeal arches 1
and 2. Dotted lines highlight pharyngeal pouches 1 and 2. Scale bars: 50 μm.
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edn1-pathway independently of Alcama. These data show that loss of
alcama and nadl1.1 causes very similar defects in cartilage morpho-
genesis and NC differentiation, supporting our hypothesis that the
two adhesion molecules might interact.
alcama and nadl1.1 are expressed adjacent to each other in the
endoderm and NC respectively (Fig. 7A), supporting our hypothesis
that Nadl1.1 may propagate Alcama differentiation signal from the
endoderm to NC. To bolster this hypothesis, we ﬁrst asked if alcama-
mediated rescue of dlx5a expression in edn1−/− mutants (Fig. 5) is
abrogated by nadl1.1 knockdown. Co-injection of nadl1.1 MO with
alcama RNA indeed blocked rescue of dlx5a expression in edn1−/−
mutants (Fig. 7B), suggesting that Nadl1.1 expression is necessary for
transmission of Edn1 signal through Alcama to NC.
To corroborate this observationwe next tested possible interaction
of Alcama and Nadl1.1 in synergy experiments by co-injecting
suboptimal doses of alcama MO and nadl1.1 MO into WT embryos.
The read-out consisted of assessment of NC differentiation (dlx5a
expression) and cartilage morphogenesis. While suboptimal doses of
alcama and nadl1.1 MOs alone do not cause signiﬁcant changes in
dlx5a expression or cartilage shape, co-injection resulted in synergis-
tic increase in the number of larvae with down-regulated dlx5a
expression and cartilage defects (Fig. 7C, D). This indicates that
Alcama and Nadl1.1 interact during cartilage morphogenesis. Taken
together with the ability of nadl1.1 MO to block rescue of NC
differentiation by Alcama over-expression in edn1−/− mutants, these
data suggest that Alcama affects cartilage and NC differentiation by
interacting with Nadl1.1.
Discussion
Our data shows for the ﬁrst time that endodermally expressed
Alcama is required for differentiation of NC and ventral pharyngeal
cartilagemorphogenesis. The alcama-deﬁcient cartilage defect resem-
bles that seen in edn1-class of mutants. In addition, edn1 regulates
Alcama protein levels in the pharyngeal endoderm. Moreover, similar
to genes involved in Edn1 signaling, alcama is dispensible for NC
patterning and migration, but is required for NC differentiation.
Additionally, alcama over-expression partially rescues the NC differ-
entiation defect in edn1−/−mutants, indicating that Alcama mediates
Edn1 signaling to NC. Finally, we identify that Nadl1.1, an interacting
partner of Alcama, is crucial for transmitting Alcama differentiation
signal to NC and promoting ventral cartilage morphogenesis. These
data lead us to propose amodel (Fig. 8), whereby Edn1 signaling turns
on dlx genes in the NC by two independent pathways. Edn1 binds to
its receptor on NC to activate NC genes directly. In parallel, Edn1 binds
to its receptor on the endoderm to stabilize Alcama protein, which in
turn binds to Nadl1.1 on NC and further activates NC genes. Activation
of both pathways is required for normal differentiation of NC and
cartilage morphogenesis.
edn1 signals to NC by two parallel pathways
Edn1 is synthesized as a proprotein, which is cleaved twice by
Furin and endothelin-converting enzyme resulting in a short, active
Edn1 peptide. This short, active Edn1 peptide binds to the G protein-
Fig. 5. alcama rescues NC differentiation defect in edn1−/− mutants. Lateral views of 30 hpf larvae with representative absent (A), partial (B) or strong (C) staining for dlx5a. Bar
graphs show the percentage dlx5a expressing larvae in edn1−/−mutants (D) and WT (E) following the stated injections. edn1 or alcama RNA was injected with or without alcama
MO. alcama RNA decreases the percentage of affected individuals (absent dlx5a staining) by nearly 30% in edn1−/−mutants and co-injection of alcamMo abrogates the ability of edn1
RNA to rescue dlx5a expression in edn1−/−mutants. Indicated p-values are calculated by Fishers exact test. n depicts the number of experiments and N depicts the total number of
larvae represented in the columns of the plot (p-valueb0.0001 for both D and E byχ2 analysis). a1 and a2 label pharyngeal arches 1 and 2. Dotted lines highlight pharyngeal pouches
1 and 2. Scale bar: 50 μm.
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coupled Edn1 receptor. Phospholipase C enzyme further transmits the
signal by producing inositol trisphosphate and diacylglycerol. Mouse
mutants for Edn1, Ednra and the G-protein share skeletal defects with
zebraﬁsh mutants for edn1, furinA and phospholipase C beta 3 (plcβ3);
the ventral domains of the lower jaw are reduced in size and fused to
the dorsal domains in both species (Clouthier et al., 1998, 2000;
Dettlaff-Swiercz et al., 2005; Kurihara et al., 1994; Miller et al., 2000;
Walker et al., 2006, 2007). Thus Edn1 signaling has been conserved
during evolution to regulate ventral cartilage morphology.
Zebraﬁsh edn1−/− and plcβ3−/−mutants have more severe ventral
cartilage reductions and joint fusions than alcama morphants. The
milder cartilage defect in alcama morphants correlates with the less
pronounced reduction of dlx, hand2 and bapx1 gene expression in NC.
We propose that this milder defect is due to two concomitant, additive
pathways for edn1 signaling; the ﬁrst acts directly in the NC through the
Edn1 receptor and the second activates Alcama signaling from the
endoderm to the NC (Fig. 8). While both pathways are affected in edn1
and plcβ3mutants, in alcamamorphants direct signaling from the Edn1
receptor is still intact and can partially activate dlx gene expression in
the NC, resulting in a milder phenotype.
Edn1 regulates alcama protein levels in pharyngeal endoderm
Previous data has implicated Edn1 as a regulator of the proteasome
pathway (Rosano et al., 2005; Sato-Jin et al., 2008). Our data suggest
that edn1 stabilizes Alcama protein by inhibiting the proteasome
pathway because inhibiting the proteasome pathway in edn1−/−
mutants results in increased Alcama levels. It is still unknown
whether Edn1 stabilizes Alcama by inducing a structural change
that prevents polyubiquitination, or indirectly by regulating tran-
scription of proteasome subunits or by activation of de-ubiquitinases.
Alternatively, Alcama may not be a direct target of the proteasome
pathway; instead a chaperone protein that stabilizes Alcamamight be
the target of proteasome pathway. An alternative possibility is that
Edn1 signals to NC and thus induces Alcama stabilization indirectly.
Further investigation into this mechanism will broaden our under-
standing of the process of NC differentiation.
Further inquiry is also needed into other proteins/signals regulat-
ing alcama expression. Although edn1 RNA injections and MG132
treatment led to higher Alcama expression, in both cases expression
was mostly restricted to the endoderm and not the NC. This data
Fig. 6. nadl1.1morphants phenocopy alcamamorphant cartilage defects. Dorsal views (A–C) and lateral views (D, E) of 30 hpf larvae. nadl1.1 is expressed in the pharyngeal arches,
diencephalon, telencephalon, hindbrain neurons, neural tube and pectoral ﬁn in 30 hpf WT larvae (A). 30 hpf nadl 1.1 morphants have down-regulated hand2 (C) and dlx5a
(E) expression as compared to uninjected WT (B, D). (F) Bar graph showing that the percentage of larvae with down-regulated (absent) dlx5a expression remains unchanged in the
p53−/− background (p-value=1.000 by Fishers exact test, indicating that WT and p53−/−mutants are not signiﬁcantly different). Dissected mandibular and hyoid elements from
5 dpf WT and nadl1.1 morphant larvae stained with Alcian blue (G, H) and their corresponding schematics (G', H'). The joint fusions in nadl1.1 morphants (H, H')
marked by * resemble those seen in alcamamorphants. (I) Bar graph comparing the percentage of larvae with affected cartilage in alcamamorphants in WT versus p53−/−mutants
(p-value=0.1941 by Fishers exact test, indicating that WT and p53−/−mutants are not signiﬁcantly different). N is the total number of larvae from three experiments. Scale bars:
50 μm.
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points to an endoderm-speciﬁc role of Alcama in cartilage formation.
Similarly, edn1 and alcama RNA injections into the one-cell stage
induced rescue of dlx5a expression, speciﬁcally in NC. Further
investigation of these mechanisms, that restrict Alcama expression
to endoderm and dlx genes to NC, is needed to gain a more complete
understanding of the process of chondrogenesis.
Alcama interacts with Nadl1.1 on the NC to mediate differentiation
signals
We established that Nadl1.1, a known interacting partner of Alcama
expressed in NC, is important for cartilage morphogenesis and its
knockdown results in similar cartilage defects to alcama knockdown.
We also demonstrated that nadl1.1 is necessary for Alcama-mediated
rescue of NC differentiation in edn1−/− mutants and that Alcama and
Nadl1.1 interact during cartilage formation, either directly or indirectly.
Hence we concluded that Nadl1.1 possibly transmits Alcama-mediated
Edn1 signaling to the NC. Future studies will focus on how Nadl1.1
activates dlx genes in the NC.
One possible function for Alcama and Nadl1.1 interaction during NC
differentiation and cartilage morphogenesis may be to simply maintain
cell–cell contacts between the endoderm and NC. Support for this
hypothesis is provided by the integrinα5 mutant and the Eph-ephrin
system. Integrins are required for cell adhesion and migration in many
tissues (Benoit et al., 2009; Brakebusch and Fassler, 2005). The zebraﬁsh
integrinα5mutant has defects in formation of the ﬁrst pouch, resulting in
defective compaction and survival of NC cells adjacent to the ﬁrst pouch,
giving rise to a deformed hyoid cartilage (Crump et al., 2004). Eph genes
encode tyrosine kinase receptors for ephrin ligands. Eph-ephrinmediated
repulsion establishes polarity and boundaries during development
(Holder and Klein, 1999; Robinson et al., 1997). Since EphA3 is expressed
Fig. 7. alcama and nadl1.1 interact during cartilage formation. (A) Lateral view of a 30 hpf WT larva stained with Zn-5 antibody (Fast Red) and anti-sense nadl1.1 RNA (Fluorescein),
revealing that nadl1.1 is expressed in the NC adjacent to alcama in the endoderm. The bar graphs display the percentage of 30 hpf edn1−/− (B) andWT (C) larvae with dlx5a staining
after the indicated injections. (B) shows that nadl1.1 is required for alcama rescue of dlx5a expression in edn1−/−mutants (p-valueb0.0001 by Fishers exact test). (C) and (D) show
that alcama and nadl1.1 interact during dlx5a expression and cartilage morphogenesis. (D) Bar graph displaying the percentage of 5 dpf larvae with affected cartilage after the















Fig. 8.Model demonstrating howAlcamamediates Edn1 signaling and NC differentiation.
Previous data has supported the model that Edn1 peptide binds to its G-protein-coupled
receptor on NC to turn on transcription of NC genes. We propose a parallel pathway by
which Edn1 signaling stabilizes Alcama protein in endodermal cells. Alcama, in turn, binds
to Nadl1.1 in NC and regulates NC differentiation.
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in ventral NC, it is also postulated that Eph-ephrin repulsion may play a
role in separating the dorsal and ventral cartilages, giving rise to the joint
between them(Kimmel et al., 2001).Hence, bothadhesive (integrins) and
repulsive forces (ephrins) play a role in NC differentiation. By analogy it is
conceivable that Alcama-Nadl1.1 mediated adhesion between the
endoderm and NC may play a similar role in chondrogenesis.
Conclusion
In summary, this is the ﬁrst demonstration that Alcama, a commonly
used marker for endoderm, plays a critical role in NC differentiation and
cartilage morphogenesis. We show that Edn1 regulates Alcama levels in
vivo and that Alcama functions downstream of Edn1 during cartilage
formation. In addition, we provide support for a mechanism by which
Alcama mediates Edn1-signaling by interacting with Nadl1.1 on NC cells.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ydbio.2010.11.006.
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DGS, the most common microdeletion syndrome, is characterized by congenital 
heart disease, craniofacial and immune system abnormalities. The T-box transcription 
factor Tbx1 has been identified as the gene responsible for causing DGS. However, the 
cardiac defects in the zebrafish tbx1
-/-
 mutant have not been characterized so far. In this 
thesis I have shown that zebrafish tbx1
-/-
 mutants have defects in heart morphology, 
looping, function and differentiation. My data suggests a model whereby heart looping 
and differentiation are regulated by tbx1 in a linear pathway through wnt11r and alcama. 
Furthermore, I show that alcama plays a crucial, nonautonomous role in pharyngeal 
endoderm during zebrafish cartilage formation, a tissue highly affected in tbx1
-/-
 mutants. 
I have demonstrated that Alcama functions downstream of Edn1, a downstream effector 
of Tbx1, to regulate NC differentiation and cartilage morphogenesis. Hence, my data 
suggests that Tbx1 regulates Alcama via Wnt11r in the heart and via Edn1 in the 
pharyngeal endoderm.  
 
4.1   Tbx1 regulates heart morphology and differentiation 
Tbx1-/- mice have a severe phenotype with single cardiac outflow tract (OFT) and 
aortic arch defects (Jerome and Papaioannou, 2001). The role of zebrafish tbx1 in cardiac 
 88 
development has not been extensively studied. By ISH analysis tbx1 is expressed in the 
mesodermal progenitors of the cardiomyocytes from the commitment phase. Hearts in 
tbx1
-/-
 mutants are incompletely looped, wider and shorter, and have weaker contractions 
and slower heart rates.  
Previous data suggest that mouse Tbx1 positively regulates SHF cell proliferation 
and SHF contribution to OFT, and negatively regulates differentiation in SHF (Chen et 
al., 2009; Liao et al., 2008; Xu et al., 2004). My findings in zebrafish show that while 
SHF cells are formed in tbx1
-/-
 mutants, the BA is not normally formed and is 
undifferentiated. Combined with data from a recent report (Hami et al., 2011), I 
concluded that SHF cells fail to migrate and integrate into the BA in tbx1
-/-
 mutants. 
Together these data suggest that the role of Tbx1 in regulating heart morphogenesis, 
especially in the outflow tract, is conserved among species.  
Study of zebrafish tbx1
-/-
 mutants has given us further insight into the mechanism 
by which tbx1 regulates heart morphology. Although the ventricle and atrium are 
specified correctly, tbx1
-/-
 mutants lack differentiation markers for the specific regions of 
the heart such as AVC. Similar to the lack of looping, lack of 
differentiation/subspecification has not been observed in mouse Tbx1-/- mutants. 
Whether lack of differentiation causes the looping defect or is an effect thereof is 
unknown. Loss of function studies for these differentiation markers suggest that 
differentiation does not affect heart looping. For example, the zebrafish bmp4 mutant and 
notch1b morphant do not have defective heart looping (Lorent et al., 2004; Stickney et 
al., 2007), suggesting that lack of expression of these differentiation markers 
accompanies but does not cause the looping defect. It is however possible that looping 
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affects differentiation as other zebrafish looping mutants and morphants have defects in 
subspecification of the heart (Brown et al., 2005; Garrity et al., 2002; Qu et al., 2008; 
Ribeiro et al., 2007; Tu et al., 2009).  
The lack of looping and differentiation may be caused by a defect in cell 
proliferation and shape. Although initial heart development proceeds normally, tbx1
-/-
 
mutants develop a reduction in cell proliferation at the onset of looping that results in 
decreased numbers of cardiomyocytes by 48 hpf. While Tbx1 regulates cell proliferation 
in mouse SHF, this is the first demonstration of its role in maintenance of proliferation in 
PHF cells. The decreased cardiomyocyte number might result in increased extracellular 
spaces in the heart.  
In addition, these cardiomyocytes fail to change their shape from rounded to 
elongated cells. While both proliferation and shape change have been shown to contribute 
to heart looping (Auman et al., 2007; Ribeiro et al., 2007), they have not been linked to 
heart differentiation. Hence, tbx1 might be necessary for maintaining cell proliferation 
and inducing shape changes that might regulate heart looping and differentiation in 
parallel or sequentially.  
 
4.2   tbx1 regulates heart morphogenesis via wnt11r 
While both Tbx1 and Wnt11r signaling have been shown to be important in heart 
morphogenesis, no link has been established to date (Arnold et al., 2006; Belema Bedada 
et al., 2005; Eisenberg et al., 1997; Merscher et al., 2001; Pandur et al., 2002). I have 
demonstrated that wnt11r is downregulated in tbx1
-/-
 mutants and that wnt11r 
-/-
 mutants 
have looping and differentiation defects similar to tbx1
-/-
 mutants, suggesting that wnt11r 
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 double heterozygotes have defective heart looping and 
differentiation, while single heterozygotes are morphologically unaffected. Furthermore, 
I was able to rescue the heart looping and differentiation defect by injection of wnt11r 
RNA or alcama RNA, a gene downstream of wnt11r, indicating that tbx1 regulates heart 
morphogenesis via wnt11r and alcama.  
In contrast to heart looping and differentiation defects, wnt11r
-/-
 mutants do not 
have the BA defects seen in tbx1
-/-
 mutants. This suggests that Tbx1 regulates BA 
morphogenesis and differentiation by a mechanism independent of Wnt11r.  
I observed an increase in extracellular spaces between the cardiomyocytes of tbx1
-
/-
 mutants. Increased extracellular spaces have also been observed in Xenopus wnt11r and 
alcama morphants (Garriock et al., 2005; Gessert et al., 2008). Alcama, a homophilic 
transmembrane adhesion molecule downstream of Tbx1, might be required for 
maintaining cell-cell contact. This would explain the increase in extracellular spaces 
obtained by knockdown of any of the three genes: tbx1, wnt11r and alcama. Close 
cellular contact might be required for the cardiomyocytes to communicate with each 
other leading to looping and differentiation. Hence looping and differentiation defects 
might be indirect effects of tbx1 knockdown. Alternatively, Alcama might regulate heart 
looping and differentiation directly and close cellular contact might be required for 
Alcama to mediate signaling.  
tbx1
-/-
 cardiomyocytes in the outer curvature fail to change their shape from 
rounded to elongated cells. I did not analyze the wnt11r
-/-
 mutant hearts for this defect.  
Wnt11 has been demonstrated to provide a directional cue to organize the elongation of 
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early muscle fibres via the planar cell polarity pathway (Gros et al., 2009). Hence it is 
possible that wnt11r regulates cell shape and secondarily heart looping via the planar cell 
polarity pathway.  
edn1 has been shown function downstream of tbx1 in zebrafish cartilage 
morphogenesis (Piotrowski et al., 2003). This is corroborated by the observation that 
mouse Edn1-/- mutants share craniofacial and heart defects similar to Tbx1-/- mutants 
(Kurihara et al., 1995; Kurihara et al., 1994). This leads to the possibility that Tbx1 
regulates heart looping via Edn1. However, zebrafish edn1 is not expressed in the 
developing heart and edn1
-/-
 mutants are not reported to have cardiac defects. While it is 
still conceivable that Edn1 functions downstream of Tbx1 in regulating heart 
development in mammals, this possibility cannot be studied using zebrafish.  
In conclusion, I have demonstrated that zebrafish tbx1 is required for normal heart 
looping, function, and differentiation. A possible mechanism by which Tbx1 regulates 
heart looping is the maintenance of cell proliferation and induction of cellular shape 
changes. Finally, I propose a model by which tbx1 regulates wnt11r that then regulates 
alcama, which in turn regulates heart looping and differentiation.  
 
4.3   Alcama is required for normal cartilage morphogenesis 
My data indicates that tbx1 regulates heart morphogenesis via wnt11r and alcama. 
Analysis of alcama morphants revealed that the ventral anterior arch cartilages are 
changed in orientation, are shorter and are fused to their dorsal counterparts. Analysis of 
earlier stages revealed that NC, endoderm and mesoderm are patterned and specified 
correctly in alcama morphants. However, late NC markers such as hand2 are strongly 
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reduced in the pharyngeal arches of alcama morphants, suggesting that alcama is 
required for NC differentiation. NC differentiation is a prerequisite to normal 
chondrogenesis and cartilage formation. Hence I concluded that similar to tbx1, alcama is 
required for NC differentiation and cartilage formation and thus alcama might function 
downstream of tbx1 during cartilage morphogenesis in addition to heart morphogenesis. 
 
4.4   Alcama functions downstream of Edn1 signaling  
The cartilage and NC differentiation phenotypes observed in alcama morphants 
are characteristic of the edn1-class of cartilage mutants (Piotrowski et al., 1996; Walker 
et al., 2006; Walker et al., 2007). Edn1 is a small signaling molecule functioning 
downstream of Tbx1, that is required nonautonomously for NC differentiation into 
cartilage (Piotrowski et al., 2003). Edn1 signals the NC and induces ventralization of 
pharyngeal arch cartilage (Miller et al., 2000). My data suggesting that alcama functions 
downstream of tbx1 in heart morphogenesis taken together with the similarity of cartilage 
defects between alcama morphants and edn1
-/-
 mutants, lead me to hypothesize that 
alcama might function downstream of edn1 during cartilage morphogenesis.  
Indeed, Alcama protein levels are downregulated in edn1
-/-
 mutants and can be 
rescued by injection of edn1 RNA, indicating that endogenous Edn1 regulates the levels 
of Alcama protein. Surprisingly, alcama RNA levels do not correlate with the severe 
down-regulation of Alcama protein levels observed in edn1
-/-
 mutants, indicating that 
edn1 regulates Alcama posttranscriptionally, perhaps at the level of translation or protein 
stability. I used the proteasome inhibitor MG132 to reveal that Edn1 inhibits the 
proteasomal degradation of Alcama.  
 93 




 mutants have downregulated levels of alcama 
RNA as well as protein. However, Alcama protein levels are more severely 
downregulated than alcama RNA levels. This suggests that Tbx1 transcriptionally 
regulates alcama RNA levels and Alcama protein is downregulated in tbx1
-/-
 mutants by a 
combination of decreased RNA expression or stability and increased protein degradation. 
Alternatively, alcama RNA and protein levels might be lower in tbx1
-/-
 mutants due to a 
decrease in the number of endodermal cells. The higher severity of cartilage defects in 
tbx1
-/-
 mutants as compared to edn1
-/-
 mutants can be explained by this lack of 
endodermal cells or by downregulation of other Tbx1 target genes. In either case, the 






I further probed my hypothesis that alcama mediates Edn1 signaling by 
overexpressing alcama in edn1
-/-
 mutants and assessing NC differentiation. Indeed, 
alcama overexpression can rescue the NC differentiation defect in edn1
-/-
 mutants, 
suggesting that alcama functions downstream of edn1 to regulate NC differentiation. 
Furthermore, knockdown of alcama can abrogate the rescue of edn1
-/-
 mutants by edn1 
overexpression, suggesting that alcama expression is necessary for Edn1 function. 
Hence, I have demonstrated that Edn1 mediates its signaling in the pharyngeal endoderm 
via Alcama.  
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4.5   Alcama interacts with Nadl1.1 on NC to  
mediate Edn1 signaling 
Alcama is a transmembrane protein expressed on the endoderm and not on NC, 
the tissue that differentiates to form cartilage. Nadl1.1, which has been shown to interact 
with Alcama in chick (DeBernardo and Chang, 1996), is expressed on NC. I have shown 
that knockdown of nadl1.1 results in cartilage and NC differentiation defects similar to 
alcama knockdown. Furthermore I demonstrated that knockdown of nadl1.1 abrogates 
the ability of alcama to rescue NC differentiation in edn1
-/-
 mutants, suggesting that 
nadl1.1 expression is necessary for Alcama to mediate Edn1 signaling. Due to lack of 
antibodies, I could not show direct interaction of Alcama on endoderm with Nadl1.1 on 
NC due to the absence of an antibody against Nadl1.1. However co-injection of 
suboptimal doses of alcama MO and nadl1.1 MO resulted in NC differentiation and 
cartilage defects, indicating that Alcama and Nadl1.1 interact during cartilage 
morphogenesis. All these data lead me to conclude that Alcama interacts with Nadl1.1 to 
mediate Edn1 signaling and regulate NC differentiation and cartilage morphogenesis. 
The difference in severity of cartilage defects between alcama morphants and 
edn1
-/-
 mutants can be explained by the additive effect of two parallel pathways. alcama 
morphants have only one pathway blocked while edn1
-/-
 mutants have both pathways 
blocked leading to a more severe defect. Similarly ednra morphants do not phenocopy 
the cartilage defects in edn1
-/-
 exactly (Nair et al., 2007). According to my model 
knockdown of ednra and ednrb together will have a more severe defect as it will block 
both pathways. In addition, my model predicts that ednrb morphants should have 
downregulation of Alcama protein.  
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An alternative possibility is that Edn1 does not need to be secreted from the 
endodermal cells to regulate Alcama. Since both Edn1 and Ednrb are synthesized in the 
endodermal cells, they might bind in the endoplasmic reticulum and signal from there 
itself. This would explain the similarity between furina
-/-
 mutants and alcama morphants 
(Choudhry et al., 2010; Walker et al., 2006). Endothelin remains in its uncleaved form in 
furina
-/-
 mutants, hence Edn1 peptide is never secreted and never binds to its receptor on 
the neural crest, blocking one pathway. However, the uncleaved Edn1 may bind to Ednrb 
in the endoplasmic reticulum of endodermal cells and stabilize Alcama levels keeping the 
second pathway active.  
Another possibility is that Edn1 regulates Nadl1.1 levels in the neural crest 
similar to how it regulates Alcama in the endoderm. While I have shown that nadl1.1 
RNA is unaffected in edn1
-/-
 mutant, I have been unable to analyze Nadl1.1 protein levels 
due to the absence of a zebrafish Nadl1.1 antibody. In this case, both Alcama and 
Nadl1.1 levels will be under the control of Edn1, making Edn1 signaling highly potent 
and sensitive to levels of Edn1.  
In conclusion, I have demonstrated that tbx1 regulates heart looping and 
differentiation via wnt11r and alcama in the heart. In parallel, tbx1 regulates edn1 and 
alcama in the pharyngeal endoderm, which in turn regulate NC differentiation and 
cartilage morphogenesis. 
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